Therapeutics: Procedures concerned with the remedial treatment or prevention of diseases.Pharmacy and Therapeutics Committee: An advisory group composed primarily of staff physicians and the pharmacist which serves as the communication link between the medical staff and the pharmacy department.Pharmacology, Clinical: The branch of pharmacology that deals directly with the effectiveness and safety of drugs in humans.Drug Delivery Systems: Systems for the delivery of drugs to target sites of pharmacological actions. Technologies employed include those concerning drug preparation, route of administration, site targeting, metabolism, and toxicity.Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.Drug Design: The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include pharmacokinetics, dosage analysis, or drug administration analysis.Molecular Targeted Therapy: Treatments with drugs which interact with or block synthesis of specific cellular components characteristic of the individual's disease in order to stop or interrupt the specific biochemical dysfunction involved in progression of the disease.Antineoplastic Agents: Substances that inhibit or prevent the proliferation of NEOPLASMS.Drug Discovery: The process of finding chemicals for potential therapeutic use.Drug Evaluation, Preclinical: Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications.Cell Line, Tumor: A cell line derived from cultured tumor cells.Nanoparticles: Nanometer-sized particles that are nanoscale in three dimensions. They include nanocrystaline materials; NANOCAPSULES; METAL NANOPARTICLES; DENDRIMERS, and QUANTUM DOTS. The uses of nanoparticles include DRUG DELIVERY SYSTEMS and cancer targeting and imaging.Nanomedicine: The branch of medicine concerned with the application of NANOTECHNOLOGY to the prevention and treatment of disease. It involves the monitoring, repair, construction, and control of human biological systems at the molecular level, using engineered nanodevices and NANOSTRUCTURES. (From Freitas Jr., Nanomedicine, vol 1, 1999).Signal Transduction: The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway.Disease Models, Animal: Naturally occurring or experimentally induced animal diseases with pathological processes sufficiently similar to those of human diseases. They are used as study models for human diseases.Drug Carriers: Forms to which substances are incorporated to improve the delivery and the effectiveness of drugs. Drug carriers are used in drug-delivery systems such as the controlled-release technology to prolong in vivo drug actions, decrease drug metabolism, and reduce drug toxicity. Carriers are also used in designs to increase the effectiveness of drug delivery to the target sites of pharmacological actions. Liposomes, albumin microspheres, soluble synthetic polymers, DNA complexes, protein-drug conjugates, and carrier erythrocytes among others have been employed as biodegradable drug carriers.Small Molecule Libraries: Large collections of small molecules (molecular weight about 600 or less), of similar or diverse nature which are used for high-throughput screening analysis of the gene function, protein interaction, cellular processing, biochemical pathways, or other chemical interactions.Clinical Trials as Topic: Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries.RNA, Small Interfering: Small double-stranded, non-protein coding RNAs (21-31 nucleotides) involved in GENE SILENCING functions, especially RNA INTERFERENCE (RNAi). Endogenously, siRNAs are generated from dsRNAs (RNA, DOUBLE-STRANDED) by the same ribonuclease, Dicer, that generates miRNAs (MICRORNAS). The perfect match of the siRNAs' antisense strand to their target RNAs mediates RNAi by siRNA-guided RNA cleavage. siRNAs fall into different classes including trans-acting siRNA (tasiRNA), repeat-associated RNA (rasiRNA), small-scan RNA (scnRNA), and Piwi protein-interacting RNA (piRNA) and have different specific gene silencing functions.Aptamers, Nucleotide: Nucleotide sequences, generated by iterative rounds of SELEX APTAMER TECHNIQUE, that bind to a target molecule specifically and with high affinity.Drugs, Investigational: Drugs which have received FDA approval for human testing but have yet to be approved for commercial marketing. This includes drugs used for treatment while they still are undergoing clinical trials (Treatment IND). The main heading includes drugs under investigation in foreign countries.Protein Engineering: Procedures by which protein structure and function are changed or created in vitro by altering existing or synthesizing new structural genes that direct the synthesis of proteins with sought-after properties. Such procedures may include the design of MOLECULAR MODELS of proteins using COMPUTER GRAPHICS or other molecular modeling techniques; site-specific mutagenesis (MUTAGENESIS, SITE-SPECIFIC) of existing genes; and DIRECTED MOLECULAR EVOLUTION techniques to create new genes.Models, Molecular: Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures.Antibodies, Monoclonal: Antibodies produced by a single clone of cells.Cell Proliferation: All of the processes involved in increasing CELL NUMBER including CELL DIVISION.RNA Interference: A gene silencing phenomenon whereby specific dsRNAs (RNA, DOUBLE-STRANDED) trigger the degradation of homologous mRNA (RNA, MESSENGER). The specific dsRNAs are processed into SMALL INTERFERING RNA (siRNA) which serves as a guide for cleavage of the homologous mRNA in the RNA-INDUCED SILENCING COMPLEX. DNA METHYLATION may also be triggered during this process.Models, Biological: Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment.Drug Therapy: The use of DRUGS to treat a DISEASE or its symptoms. One example is the use of ANTINEOPLASTIC AGENTS to treat CANCER.High-Throughput Screening Assays: Rapid methods of measuring the effects of an agent in a biological or chemical assay. The assay usually involves some form of automation or a way to conduct multiple assays at the same time using sample arrays.Apoptosis: One of the mechanisms by which CELL DEATH occurs (compare with NECROSIS and AUTOPHAGOCYTOSIS). Apoptosis is the mechanism responsible for the physiological deletion of cells and appears to be intrinsically programmed. It is characterized by distinctive morphologic changes in the nucleus and cytoplasm, chromatin cleavage at regularly spaced sites, and the endonucleolytic cleavage of genomic DNA; (DNA FRAGMENTATION); at internucleosomal sites. This mode of cell death serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth.Xenograft Model Antitumor Assays: In vivo methods of screening investigative anticancer drugs, biologic response modifiers or radiotherapies. Human tumor tissue or cells are transplanted into mice or rats followed by tumor treatment regimens. A variety of outcomes are monitored to assess antitumor effectiveness.Biological Products: Complex pharmaceutical substances, preparations, or matter derived from organisms usually obtained by biological methods or assay.Individualized Medicine: Therapeutic approach tailoring therapy for genetically defined subgroups of patients.Peptides: Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are linear polypeptides that are normally synthesized on RIBOSOMES.Protein Binding: The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments.Polymers: Compounds formed by the joining of smaller, usually repeating, units linked by covalent bonds. These compounds often form large macromolecules (e.g., BIOPOLYMERS; PLASTICS).Pharmaceutical Preparations: Drugs intended for human or veterinary use, presented in their finished dosage form. Included here are materials used in the preparation and/or formulation of the finished dosage form.Cell Line: Established cell cultures that have the potential to propagate indefinitely.Molecular Sequence Data: Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories.Immunotherapy: Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection.Biopharmaceutics: The study of the physical and chemical properties of a drug and its dosage form as related to the onset, duration, and intensity of its action.Inhibitory Concentration 50: The concentration of a compound needed to reduce population growth of organisms, including eukaryotic cells, by 50% in vitro. Though often expressed to denote in vitro antibacterial activity, it is also used as a benchmark for cytotoxicity to eukaryotic cells in culture.Molecular Structure: The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds.Cell Survival: The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability.Enzyme Inhibitors: Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction.Nanotechnology: The development and use of techniques to study physical phenomena and construct structures in the nanoscale size range or smaller.Oligonucleotides, Antisense: Short fragments of DNA or RNA that are used to alter the function of target RNAs or DNAs to which they hybridize.Convection: Transmission of energy or mass by a medium involving movement of the medium itself. The circulatory movement that occurs in a fluid at a nonuniform temperature owing to the variation of its density and the action of gravity. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed; Webster, 10th ed)Protein Kinase Inhibitors: Agents that inhibit PROTEIN KINASES.Central Nervous System Agents: A class of drugs producing both physiological and psychological effects through a variety of mechanisms. They can be divided into "specific" agents, e.g., affecting an identifiable molecular mechanism unique to target cells bearing receptors for that agent, and "nonspecific" agents, those producing effects on different target cells and acting by diverse molecular mechanisms. Those with nonspecific mechanisms are generally further classed according to whether they produce behavioral depression or stimulation. Those with specific mechanisms are classed by locus of action or specific therapeutic use. (From Gilman AG, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p252)Amino Acid Sequence: The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION.Mice, Nude: Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses.Structure-Activity Relationship: The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups.Mice, Inbred C57BLBioengineering: The application of engineering principles and methods to living organisms or biological systems.Cell-Penetrating Peptides: Peptides that have the ability to enter cells by crossing the plasma membrane directly, or through uptake by the endocytotic pathway.Translational Medical Research: The application of discoveries generated by laboratory research and preclinical studies to the development of clinical trials and studies in humans. A second area of translational research concerns enhancing the adoption of best practices.Biotechnology: Body of knowledge related to the use of organisms, cells or cell-derived constituents for the purpose of developing products which are technically, scientifically and clinically useful. Alteration of biologic function at the molecular level (i.e., GENETIC ENGINEERING) is a central focus; laboratory methods used include TRANSFECTION and CLONING technologies, sequence and structure analysis algorithms, computer databases, and gene and protein structure function analysis and prediction.Drug Approval: Process that is gone through in order for a drug to receive approval by a government regulatory agency. This includes any required pre-clinical or clinical testing, review, submission, and evaluation of the applications and test results, and post-marketing surveillance of the drug.Drug Resistance, Neoplasm: Resistance or diminished response of a neoplasm to an antineoplastic agent in humans, animals, or cell or tissue cultures.Ligands: A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed)Gene Expression Regulation, Neoplastic: Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in neoplastic tissue.Protein Structure, Tertiary: The level of protein structure in which combinations of secondary protein structures (alpha helices, beta sheets, loop regions, and motifs) pack together to form folded shapes called domains. Disulfide bridges between cysteines in two different parts of the polypeptide chain along with other interactions between the chains play a role in the formation and stabilization of tertiary structure. Small proteins usually consist of only one domain but larger proteins may contain a number of domains connected by segments of polypeptide chain which lack regular secondary structure.MicroRNAs: Small double-stranded, non-protein coding RNAs, 21-25 nucleotides in length generated from single-stranded microRNA gene transcripts by the same RIBONUCLEASE III, Dicer, that produces small interfering RNAs (RNA, SMALL INTERFERING). They become part of the RNA-INDUCED SILENCING COMPLEX and repress the translation (TRANSLATION, GENETIC) of target RNA by binding to homologous 3'UTR region as an imperfect match. The small temporal RNAs (stRNAs), let-7 and lin-4, from C. elegans, are the first 2 miRNAs discovered, and are from a class of miRNAs involved in developmental timing.Drug Screening Assays, Antitumor: Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals.Formularies as Topic: Works about lists of drugs or collections of recipes, formulas, and prescriptions for the compounding of medicinal preparations. Formularies differ from PHARMACOPOEIAS in that they are less complete, lacking full descriptions of the drugs, their formulations, analytic composition, chemical properties, etc. In hospitals, formularies list all drugs commonly stocked in the hospital pharmacy.Technology, Pharmaceutical: The application of scientific knowledge or technology to pharmacy and the pharmaceutical industry. It includes methods, techniques, and instrumentation in the manufacture, preparation, compounding, dispensing, packaging, and storing of drugs and other preparations used in diagnostic and determinative procedures, and in the treatment of patients.Peptide Library: A collection of cloned peptides, or chemically synthesized peptides, frequently consisting of all possible combinations of amino acids making up an n-amino acid peptide.Nucleic Acids: High molecular weight polymers containing a mixture of purine and pyrimidine nucleotides chained together by ribose or deoxyribose linkages.Mice, SCID: Mice homozygous for the mutant autosomal recessive gene "scid" which is located on the centromeric end of chromosome 16. These mice lack mature, functional lymphocytes and are thus highly susceptible to lethal opportunistic infections if not chronically treated with antibiotics. The lack of B- and T-cell immunity resembles severe combined immunodeficiency (SCID) syndrome in human infants. SCID mice are useful as animal models since they are receptive to implantation of a human immune system producing SCID-human (SCID-hu) hematochimeric mice.Biological Therapy: Treatment of diseases with biological materials or biological response modifiers, such as the use of GENES; CELLS; TISSUES; organs; SERUM; VACCINES; and humoral agents.Mutation: Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations.Dose-Response Relationship, Drug: The relationship between the dose of an administered drug and the response of the organism to the drug.Antiviral Agents: Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly.Mice, Transgenic: Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN.Antibodies, Bispecific: Antibodies, often monoclonal, in which the two antigen-binding sites are specific for separate ANTIGENIC DETERMINANTS. They are artificial antibodies produced by chemical crosslinking, fusion of HYBRIDOMA cells, or by molecular genetic techniques. They function as the main mediators of targeted cellular cytotoxicity and have been shown to be efficient in the targeting of drugs, toxins, radiolabeled haptens, and effector cells to diseased tissue, primarily tumors.Cells, Cultured: Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others.Alzheimer Disease: A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)Therapies, Investigational: Treatments which are undergoing clinical trials or for which there is insufficient evidence to determine their effects on health outcomes; coverage for such treatments is often denied by health insurers.Mice, Inbred BALB CNanostructures: Materials which have structured components with at least one dimension in the range of 1 to 100 nanometers. These include NANOCOMPOSITES; NANOPARTICLES; NANOTUBES; and NANOWIRES.Cell- and Tissue-Based Therapy: Therapies that involve the TRANSPLANTATION of CELLS or TISSUES developed for the purpose of restoring the function of diseased or dysfunctional cells or tissues.Oligonucleotides: Polymers made up of a few (2-20) nucleotides. In molecular genetics, they refer to a short sequence synthesized to match a region where a mutation is known to occur, and then used as a probe (OLIGONUCLEOTIDE PROBES). (Dorland, 28th ed)HEK293 Cells: A cell line generated from human embryonic kidney cells that were transformed with human adenovirus type 5.Single-Chain Antibodies: A form of antibodies consisting only of the variable regions of the heavy and light chains (FV FRAGMENTS), connected by a small linker peptide. They are less immunogenic than complete immunoglobulin and thus have potential therapeutic use.Biomarkers, Pharmacological: Measurable biological parameters that serve for drug development, safety and dosing (DRUG MONITORING).Blotting, Western: Identification of proteins or peptides that have been electrophoretically separated by blot transferring from the electrophoresis gel to strips of nitrocellulose paper, followed by labeling with antibody probes.Nanoconjugates: Tailored macromolecules harboring covalently-bound biologically active modules that target specific tissues and cells. The active modules or functional groups can include drugs, prodrugs, antibodies, and oligonucleotides, which can act synergistically and be multitargeting.Diagnostic Imaging: Any visual display of structural or functional patterns of organs or tissues for diagnostic evaluation. It includes measuring physiologic and metabolic responses to physical and chemical stimuli, as well as ultramicroscopy.Botulinum Antitoxin: Antiserum given therapeutically in BOTULISM.Pharmacology: The study of the origin, nature, properties, and actions of drugs and their effects on living organisms.Genetic Vectors: DNA molecules capable of autonomous replication within a host cell and into which other DNA sequences can be inserted and thus amplified. Many are derived from PLASMIDS; BACTERIOPHAGES; or VIRUSES. They are used for transporting foreign genes into recipient cells. Genetic vectors possess a functional replicator site and contain GENETIC MARKERS to facilitate their selective recognition.Inflammation: A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.Crystallography, X-Ray: The study of crystal structure using X-RAY DIFFRACTION techniques. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)Recombinant Proteins: Proteins prepared by recombinant DNA technology.Gene Expression Profiling: The determination of the pattern of genes expressed at the level of GENETIC TRANSCRIPTION, under specific circumstances or in a specific cell.Angiogenesis Inhibitors: Agents and endogenous substances that antagonize or inhibit the development of new blood vessels.Breast Neoplasms: Tumors or cancer of the human BREAST.Drug Repositioning: The deliberate and methodical practice of finding new applications for existing drugs.Neurodegenerative Diseases: Hereditary and sporadic conditions which are characterized by progressive nervous system dysfunction. These disorders are often associated with atrophy of the affected central or peripheral nervous system structures.Pharmacogenetics: A branch of genetics which deals with the genetic variability in individual responses to drugs and drug metabolism (BIOTRANSFORMATION).Molecular Medicine: The field of medicine concerned with understanding the biochemical basis of health and disease and involved in developing diagnostic and therapeutic methods that utilize MOLECULAR BIOLOGY techniques.Histone Deacetylase Inhibitors: Compounds that inhibit HISTONE DEACETYLASES. This class of drugs may influence gene expression by increasing the level of acetylated HISTONES in specific CHROMATIN domains.Dendrimers: Tree-like, highly branched, polymeric compounds. They grow three-dimensionally by the addition of shells of branched molecules to a central core. The overall globular shape and presence of cavities gives potential as drug carriers and CONTRAST AGENTS.Gene Transfer Techniques: The introduction of functional (usually cloned) GENES into cells. A variety of techniques and naturally occurring processes are used for the gene transfer such as cell hybridization, LIPOSOMES or microcell-mediated gene transfer, ELECTROPORATION, chromosome-mediated gene transfer, TRANSFECTION, and GENETIC TRANSDUCTION. Gene transfer may result in genetically transformed cells and individual organisms.Clinical Trials, Phase I as Topic: Works about studies performed to evaluate the safety of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques in healthy subjects and to determine the safe dosage range (if appropriate). These tests also are used to determine pharmacologic and pharmacokinetic properties (toxicity, metabolism, absorption, elimination, and preferred route of administration). They involve a small number of persons and usually last about 1 year. This concept includes phase I studies conducted both in the U.S. and in other countries.Molecular Docking Simulation: A computer simulation technique that is used to model the interaction between two molecules. Typically the docking simulation measures the interactions of a small molecule or ligand with a part of a larger molecule such as a protein.Regenerative Medicine: A field of medicine concerned with developing and using strategies aimed at repair or replacement of damaged, diseased, or metabolically deficient organs, tissues, and cells via TISSUE ENGINEERING; CELL TRANSPLANTATION; and ARTIFICIAL ORGANS and BIOARTIFICIAL ORGANS and tissues.Binding Sites: The parts of a macromolecule that directly participate in its specific combination with another molecule.Gene Expression Regulation: Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation.Brain: The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM.Central Nervous System Diseases: Diseases of any component of the brain (including the cerebral hemispheres, diencephalon, brain stem, and cerebellum) or the spinal cord.Polyethylene Glycols: Polymers of ETHYLENE OXIDE and water, and their ethers. They vary in consistency from liquid to solid depending on the molecular weight indicated by a number following the name. They are used as SURFACTANTS, dispersing agents, solvents, ointment and suppository bases, vehicles, and tablet excipients. Some specific groups are NONOXYNOLS, OCTOXYNOLS, and POLOXAMERS.Neovascularization, Pathologic: A pathologic process consisting of the proliferation of blood vessels in abnormal tissues or in abnormal positions.Molecular Imaging: The use of molecularly targeted imaging probes to localize and/or monitor biochemical and cellular processes via various imaging modalities that include RADIONUCLIDE IMAGING; ULTRASONOGRAPHY; MAGNETIC RESONANCE IMAGING; FLUORESCENCE IMAGING; and MICROSCOPY.Filoviridae Infections: Infections with viruses of the family FILOVIRIDAE. The infections in humans consist of a variety of clinically similar viral hemorrhagic fevers but the natural reservoir host is unknown.Antibodies: Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).Blood-Brain Barrier: Specialized non-fenestrated tightly-joined ENDOTHELIAL CELLS with TIGHT JUNCTIONS that form a transport barrier for certain substances between the cerebral capillaries and the BRAIN tissue.Gene Silencing: Interruption or suppression of the expression of a gene at transcriptional or translational levels.Gene Knockdown Techniques: The artificial induction of GENE SILENCING by the use of RNA INTERFERENCE to reduce the expression of a specific gene. It includes the use of DOUBLE-STRANDED RNA, such as SMALL INTERFERING RNA and RNA containing HAIRPIN LOOP SEQUENCE, and ANTI-SENSE OLIGONUCLEOTIDES.Liposomes: Artificial, single or multilaminar vesicles (made from lecithins or other lipids) that are used for the delivery of a variety of biological molecules or molecular complexes to cells, for example, drug delivery and gene transfer. They are also used to study membranes and membrane proteins.Drug Industry: That segment of commercial enterprise devoted to the design, development, and manufacture of chemical products for use in the diagnosis and treatment of disease, disability, or other dysfunction, or to improve function.Delayed-Action Preparations: Dosage forms of a drug that act over a period of time by controlled-release processes or technology.Flow Cytometry: Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake.Transfection: The uptake of naked or purified DNA by CELLS, usually meaning the process as it occurs in eukaryotic cells. It is analogous to bacterial transformation (TRANSFORMATION, BACTERIAL) and both are routinely employed in GENE TRANSFER TECHNIQUES.Amyloid beta-Peptides: Peptides generated from AMYLOID BETA-PEPTIDES PRECURSOR. An amyloid fibrillar form of these peptides is the major component of amyloid plaques found in individuals with Alzheimer's disease and in aged individuals with trisomy 21 (DOWN SYNDROME). The peptide is found predominantly in the nervous system, but there have been reports of its presence in non-neural tissue.Reverse Transcriptase Polymerase Chain Reaction: A variation of the PCR technique in which cDNA is made from RNA via reverse transcription. The resultant cDNA is then amplified using standard PCR protocols.Mice, Knockout: Strains of mice in which certain GENES of their GENOMES have been disrupted, or "knocked-out". To produce knockouts, using RECOMBINANT DNA technology, the normal DNA sequence of the gene being studied is altered to prevent synthesis of a normal gene product. Cloned cells in which this DNA alteration is successful are then injected into mouse EMBRYOS to produce chimeric mice. The chimeric mice are then bred to yield a strain in which all the cells of the mouse contain the disrupted gene. Knockout mice are used as EXPERIMENTAL ANIMAL MODELS for diseases (DISEASE MODELS, ANIMAL) and to clarify the functions of the genes.Viruses: Minute infectious agents whose genomes are composed of DNA or RNA, but not both. They are characterized by a lack of independent metabolism and the inability to replicate outside living host cells.Societies, Pharmaceutical: Societies whose membership is limited to pharmacists.Protein Conformation: The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain).RNA, Messenger: RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm.Immunoconjugates: Combinations of diagnostic or therapeutic substances linked with specific immune substances such as IMMUNOGLOBULINS; MONOCLONAL ANTIBODIES; or ANTIGENS. Often the diagnostic or therapeutic substance is a radionuclide. These conjugates are useful tools for specific targeting of DRUGS and RADIOISOTOPES in the CHEMOTHERAPY and RADIOIMMUNOTHERAPY of certain cancers.Protein Stability: The ability of a protein to retain its structural conformation or its activity when subjected to physical or chemical manipulations.Ebolavirus: A genus in the family FILOVIRIDAE consisting of several distinct species of Ebolavirus, each containing separate strains. These viruses cause outbreaks of a contagious, hemorrhagic disease (HEMORRHAGIC FEVER, EBOLA) in humans, usually with high mortality.Antibodies, Monoclonal, Humanized: Antibodies from non-human species whose protein sequences have been modified to make them nearly identical with human antibodies. If the constant region and part of the variable region are replaced, they are called humanized. If only the constant region is modified they are called chimeric. INN names for humanized antibodies end in -zumab.Recombinant Fusion Proteins: Recombinant proteins produced by the GENETIC TRANSLATION of fused genes formed by the combination of NUCLEIC ACID REGULATORY SEQUENCES of one or more genes with the protein coding sequences of one or more genes.Stem Cell Transplantation: The transfer of STEM CELLS from one individual to another within the same species (TRANSPLANTATION, HOMOLOGOUS) or between species (XENOTRANSPLANTATION), or transfer within the same individual (TRANSPLANTATION, AUTOLOGOUS). The source and location of the stem cells determines their potency or pluripotency to differentiate into various cell types.Time Factors: Elements of limited time intervals, contributing to particular results or situations.Neoplasm Transplantation: Experimental transplantation of neoplasms in laboratory animals for research purposes.Education, Pharmacy: Formal instruction, learning, or training in the preparation, dispensing, and proper utilization of drugs in the field of medicine.Transplantation, Heterologous: Transplantation between animals of different species.Genetic Engineering: Directed modification of the gene complement of a living organism by such techniques as altering the DNA, substituting genetic material by means of a virus, transplanting whole nuclei, transplanting cell hybrids, etc.Chemistry, Pharmaceutical: Chemistry dealing with the composition and preparation of agents having PHARMACOLOGIC ACTIONS or diagnostic use.Prostatic Neoplasms: Tumors or cancer of the PROSTATE.Cardiotoxins: Agents that have a damaging effect on the HEART. Such damage can occur from ALKYLATING AGENTS; FREE RADICALS; or metabolites from OXIDATIVE STRESS and in some cases is countered by CARDIOTONIC AGENTS. Induction of LONG QT SYNDROME or TORSADES DE POINTES has been the reason for viewing some drugs as cardiotoxins.Virus Replication: The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle.Cell Differentiation: Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs.Survival of Motor Neuron 2 Protein: A SMN complex protein that is closely-related to SURVIVAL OF MOTOR NEURON 1 PROTEIN. In humans, the protein is encoded by an often duplicated gene found near the inversion centromere of a large inverted region of CHROMOSOME 5.Tumor Markers, Biological: Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or body fluids. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including hormones, antigens, amino and nucleic acids, enzymes, polyamines, and specific cell membrane proteins and lipids.Pyridines: Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.Textbooks as Topic: Books used in the study of a subject that contain a systematic presentation of the principles and vocabulary of a subject.ThiazolesOncolytic Virotherapy: Use of attenuated VIRUSES as ANTINEOPLASTIC AGENTS to selectively kill CANCER cells.Anti-Inflammatory Agents: Substances that reduce or suppress INFLAMMATION.Immunologic Factors: Biologically active substances whose activities affect or play a role in the functioning of the immune system.Benzamides: BENZOIC ACID amides.Clinical Trials, Phase II as Topic: Works about studies that are usually controlled to assess the effectiveness and dosage (if appropriate) of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques. These studies are performed on several hundred volunteers, including a limited number of patients with the target disease or disorder, and last about two years. This concept includes phase II studies conducted in both the U.S. and in other countries.Immunomodulation: Alteration of the immune system or of an immune response by agents that activate or suppress its function. This can include IMMUNIZATION or administration of immunomodulatory drugs. Immunomodulation can also encompass non-therapeutic alteration of the immune system effected by endogenous or exogenous substances.Immunotoxins: Semisynthetic conjugates of various toxic molecules, including RADIOACTIVE ISOTOPES and bacterial or plant toxins, with specific immune substances such as IMMUNOGLOBULINS; MONOCLONAL ANTIBODIES; and ANTIGENS. The antitumor or antiviral immune substance carries the toxin to the tumor or infected cell where the toxin exerts its poisonous effect.Medical Oncology: A subspecialty of internal medicine concerned with the study of neoplasms.Receptor, Epidermal Growth Factor: A cell surface receptor involved in regulation of cell growth and differentiation. It is specific for EPIDERMAL GROWTH FACTOR and EGF-related peptides including TRANSFORMING GROWTH FACTOR ALPHA; AMPHIREGULIN; and HEPARIN-BINDING EGF-LIKE GROWTH FACTOR. The binding of ligand to the receptor causes activation of its intrinsic tyrosine kinase activity and rapid internalization of the receptor-ligand complex into the cell.Tumor Cells, Cultured: Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely.Receptors, G-Protein-Coupled: The largest family of cell surface receptors involved in SIGNAL TRANSDUCTION. They share a common structure and signal through HETEROTRIMERIC G-PROTEINS.Phosphorylation: The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety.Virus Internalization: The entering of cells by viruses following VIRUS ATTACHMENT. This is achieved by ENDOCYTOSIS, by direct MEMBRANE FUSION of the viral membrane with the CELL MEMBRANE, or by translocation of the whole virus across the cell membrane.Oncolytic Viruses: Tumor-selective, replication competent VIRUSES that have antineoplastic effects. This is achieved by producing cytotoxicity-enhancing proteins and/or eliciting an antitumor immune response. They are genetically engineered so that they can replicate in CANCER cells but not in normal cells, and are used in ONCOLYTIC VIROTHERAPY.Combinatorial Chemistry Techniques: A technology, in which sets of reactions for solution or solid-phase synthesis, is used to create molecular libraries for analysis of compounds on a large scale.Surface Plasmon Resonance: A biosensing technique in which biomolecules capable of binding to specific analytes or ligands are first immobilized on one side of a metallic film. Light is then focused on the opposite side of the film to excite the surface plasmons, that is, the oscillations of free electrons propagating along the film's surface. The refractive index of light reflecting off this surface is measured. When the immobilized biomolecules are bound by their ligands, an alteration in surface plasmons on the opposite side of the film is created which is directly proportional to the change in bound, or adsorbed, mass. Binding is measured by changes in the refractive index. The technique is used to study biomolecular interactions, such as antigen-antibody binding.Genomics: The systematic study of the complete DNA sequences (GENOME) of organisms.Proteasome Inhibitors: Compounds that inhibit the function or proteolytic action of the PROTEASOME.Drug Synergism: The action of a drug in promoting or enhancing the effectiveness of another drug.SELEX Aptamer Technique: A method of generating a large library of randomized nucleotides and selecting NUCLEOTIDE APTAMERS by iterative rounds of in vitro selection. A modified procedure substitutes AMINO ACIDS in place of NUCLEOTIDES to make PEPTIDE APTAMERS.Disease Progression: The worsening of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis.Proteins: Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein.Brain Neoplasms: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.HeLa Cells: The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for VIRUS CULTIVATION and antitumor drug screening assays.PiperazinesCytokines: Non-antibody proteins secreted by inflammatory leukocytes and some non-leukocytic cells, that act as intercellular mediators. They differ from classical hormones in that they are produced by a number of tissue or cell types rather than by specialized glands. They generally act locally in a paracrine or autocrine rather than endocrine manner.Biological Markers: Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, environmental exposure and its effects, disease diagnosis, metabolic processes, substance abuse, pregnancy, cell line development, epidemiologic studies, etc.Neoplastic Stem Cells: Highly proliferative, self-renewing, and colony-forming stem cells which give rise to NEOPLASMS.Models, Animal: Non-human animals, selected because of specific characteristics, for use in experimental research, teaching, or testing.Curcumin: A yellow-orange dye obtained from tumeric, the powdered root of CURCUMA longa. It is used in the preparation of curcuma paper and the detection of boron. Curcumin appears to possess a spectrum of pharmacological properties, due primarily to its inhibitory effects on metabolic enzymes.Treatment Outcome: Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.Immunohistochemistry: Histochemical localization of immunoreactive substances using labeled antibodies as reagents.Cricetinae: A subfamily in the family MURIDAE, comprising the hamsters. Four of the more common genera are Cricetus, CRICETULUS; MESOCRICETUS; and PHODOPUS.Product Recalls and Withdrawals: The removal of a consumer product from the market place. The reason for the removal can be due a variety of causes, including the discovery of a manufacturing defect, a safety issue with the product's use, or marketing decisions.Mice, Inbred NOD: A strain of non-obese diabetic mice developed in Japan that has been widely studied as a model for T-cell-dependent autoimmune insulin-dependent diabetes mellitus in which insulitis is a major histopathologic feature, and in which genetic susceptibility is strongly MHC-linked.Cricetulus: A genus of the family Muridae consisting of eleven species. C. migratorius, the grey or Armenian hamster, and C. griseus, the Chinese hamster, are the two species used in biomedical research.Pyrimidines: A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.Cercopithecus aethiops: A species of CERCOPITHECUS containing three subspecies: C. tantalus, C. pygerythrus, and C. sabeus. They are found in the forests and savannah of Africa. The African green monkey (C. pygerythrus) is the natural host of SIMIAN IMMUNODEFICIENCY VIRUS and is used in AIDS research.Polyethyleneimine: Strongly cationic polymer that binds to certain proteins; used as a marker in immunology, to precipitate and purify enzymes and lipids. Synonyms: aziridine polymer; Epamine; Epomine; ethylenimine polymer; Montrek; PEI; Polymin(e).Cell Death: The termination of the cell's ability to carry out vital functions such as metabolism, growth, reproduction, responsiveness, and adaptability.Particle Size: Relating to the size of solids.Antibodies, Neutralizing: Antibodies that reduce or abolish some biological activity of a soluble antigen or infectious agent, usually a virus.Indoles: Benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to ISOINDOLES which have the nitrogen away from the six-membered ring.Peptidomimetics: Compounds that are designed to mimic the 3D structure of a natural peptide or protein.Immunoglobulin Fc Fragments: Crystallizable fragments composed of the carboxy-terminal halves of both IMMUNOGLOBULIN HEAVY CHAINS linked to each other by disulfide bonds. Fc fragments contain the carboxy-terminal parts of the heavy chain constant regions that are responsible for the effector functions of an immunoglobulin (COMPLEMENT fixation, binding to the cell membrane via FC RECEPTORS, and placental transport). This fragment can be obtained by digestion of immunoglobulins with the proteolytic enzyme PAPAIN.Biocompatible Materials: Synthetic or natural materials, other than DRUGS, that are used to replace or repair any body TISSUES or bodily function.Disease: A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.Kinetics: The rate dynamics in chemical or physical systems.

*  Cornerstone Therapeutics Inc. Stockholders Seeking More Money Regarding the Proposed Buyout by Chies
Cornerstone Therapeutics Inc. Stockholders Seeking More Money ... Cornerstone Therapeutics Inc. Stockholders Seeking More Money ... of Cornerstone Therapeutics Inc. NASDAQ: CRTX in connection with a ... Breaking Medicine News 10 mins : Health News:New Government Benchmark Health Data Key for Doctors Considering Capitation, and Value-Based Rick Arrangements 2 Health News:New Government Benchmark Health Data Key for Doctors Considering Capitation, and Value-Based Rick Arrangements 3 Health News:New Immunotherapy for Lung Cancer Offers Hope to Patients, SITC Reacts 2 Health News:New Immunotherapy for Lung Cancer Offers Hope to Patients, SITC Reacts 3 Health News:Baptist Medical Center Jacksonville First in Region to Use New Heart Device Approved for Use with MRI Scans 2 Health News:Baptist Medical Center Jacksonville First in Region to Use New Heart Device Approved for Use with MRI Scans 3 Health News:Following Recent Tragedy at Oregon School, Slide To Safety, Developer of Patented 6 Second Rapid Evacuat...
http://bio-medicine.org/medicine-technology-1/Cornerstone-Therapeutics-Inc--Stockholders-Seeking-More-Money-Regarding-the-Proposed-Buyout-by-Chiesi-Farmaceutici-S-P-A--Encouraged-to-Contact-Lawyer-36044-1/
*  Mortality from Pneumonia in Children in the United States, 1939 through 1996
... Skip to Main Content. Log In/Create Account Find Analyze Data. Membership in ICPSR. Deposit Data. Resources for Instructors. Data Management Curation. Find Analyze Data. Find Data. Search/Compare Variables. Find Publications. Resources for Students. series: National Hospital Discharge Survey Series study: National Hospital Discharge Survey, 1988. Mortality from Pneumonia in Children in the United States, 1939 through 1996. Citation The following citation is from the ICPSR Bibliography of Data-related Literature :. Dowell, Scott F., Kupronis, Benjamin A., Zell, Elizabeth R. Mortality from Pneumonia in Children in the United States, 1939 through 1996. doi:10.1056/NEJM200005113421904 Full Text: DOI WorldCat Google Scholar Export Citation: RIS EndNote XML. Related Data This citation is related to the following data: National Hospital Discharge Survey, 1970 National Hospital Discharge Survey, 1973 National Hospital Discharge Survey, 1974 National Hospital Discharge Survey, 1975 National Hospital Discharge Sur...
http://icpsr.umich.edu/icpsrweb/ICPSR/biblio/studies/9521/resources/8738?collection=DATA&sortBy=1
*  Study Search Results
1 National Hospital Discharge Survey, 2008. ICPSR 30182 United States Department of Health and Human Services. Centers for Disease Control and Prevention. 2 National Hospital Discharge Survey, 2007. ICPSR 28162 United States Department of Health and Human Services. Centers for Disease Control and Prevention. 3 National Hospital Discharge Survey, 1979-2006: Multi-Year Public Use File. ICPSR 24281 United States Department of Health and Human Services. 4 National Hospital Discharge Survey, 2006. ICPSR 22745 United States Department of Health and Human Services. 5 National Hospital Discharge Survey, 2005. ICPSR 20380 United States Department of Health and Human Services. 6 National Hospital Discharge Survey, 2004. ICPSR 4442 United States Department of Health and Human Services. 7 National Hospital Discharge Survey, 2003. ICPSR 4220 United States Department of Health and Human Services. National Center for Health Statistics. 8 National Hospital Discharge Survey, 2002. ICPSR 4166 United States Department of Health...
http://icpsr.umich.edu/icpsrweb/ICPSR/series/43/studies?keyword[0]=hospitals&sortBy=7&permit[0]=AVAILABLE&archive=ICPSR&dataFormat[0]=SAS&paging.startRow=1
*  Study Search Results
1 National Hospital Discharge Survey, 2008. ICPSR 30182 United States Department of Health and Human Services. Centers for Disease Control and Prevention. 2 National Hospital Discharge Survey, 2007. ICPSR 28162 United States Department of Health and Human Services. Centers for Disease Control and Prevention. 3 National Hospital Discharge Survey, 1979-2006: Multi-Year Public Use File. ICPSR 24281 United States Department of Health and Human Services. 4 National Hospital Discharge Survey, 2006. ICPSR 22745 United States Department of Health and Human Services. 5 National Hospital Discharge Survey, 2005. ICPSR 20380 United States Department of Health and Human Services. 6 National Hospital Discharge Survey, 2004. ICPSR 4442 United States Department of Health and Human Services. 7 National Hospital Discharge Survey, 2003. ICPSR 4220 United States Department of Health and Human Services. National Center for Health Statistics. 8 National Hospital Discharge Survey, 2002. ICPSR 4166 United States Department of Health...
http://icpsr.umich.edu/icpsrweb/ICPSR/series/43/studies?keyword[0]=illness&sortBy=7&archive=ICPSR&dataFormat[0]=SPSS&paging.startRow=1
*  National Hospital Discharge Survey, 2008
... Find Analyze Data. Metadata Exports. Download Statistics. National Hospital Discharge Survey, 2008 ICPSR 30182 Principal Investigator s : United States Department of Health and Human Services. National Center for Health Statistics Summary: The 2008 National Hospital Discharge Survey NHDS collects medical and demographic information annually from a sample of hospital discharge records. more info The 2008 National Hospital Discharge Survey NHDS collects medical and demographic information annually from a sample of hospital discharge records. Variables include patients' demographic characteristics sex, age, race, marital status, date of discharge, source and type of admission, status at discharge, final diagnoses, surgical and nonsurgical procedures, dates of surgeries, and sources of payment. National Hospital Discharge Survey, 2008 - Download All Files 151.9 MB large dataset. Data: SAS SPSS Stata ASCII Delimited ASCII + SAS Setup SPSS Setup Stata Setup. National Center for Health Statistics. National Hosp...
http://icpsr.umich.edu/icpsrweb/ICPSR/series/43/studies/30182?sortBy=7&permit[0]=AVAILABLE&archive=ICPSR&keyword[0]=illness&paging.startRow=1
*  National Hospital Discharge Survey, 2006
... Metadata Exports. National Hospital Discharge Survey, 2006 ICPSR 22745 Principal Investigator s : United States Department of Health and Human Services. National Center for Health Statistics Summary: The 2006 National Hospital Discharge Survey NHDS collects medical and demographic information annually from a sample of hospital discharge records. Variables include patients demographic characteristics sex, age, race, marital status, dates of admission and discharge, source and type of admission, status at discharge, final diagnoses, surgical and nonsurgical procedures, dates of surgeries, and sources of payment. more info The 2006 National Hospital Discharge Survey NHDS collects medical and demographic information annually from a sample of hospital discharge records. Study Description Citation United States Department of Health and Human Services. National Center for Health Statistics. National Hospital Discharge Survey, 2006. health care facilities, hospitalization, hospitals, illness, medical care, medic...
http://icpsr.umich.edu/icpsrweb/ICPSR/series/43/studies/22745?sortBy=7&permit[0]=AVAILABLE&archive=ICPSR&dataFormat[0]=SPSS&paging.startRow=1
*  Series
... Skip to Main Content. Toggle navigation. Home. Announcements. About Us. What is DSDR. Our Mission. Meet the Team. Contact Us. Find Data. Search Holdings. Restricted Data. NICHD Funded Studies. Analyze Data Online. Search/Compare Variables. Publications. Deposit Data. Search for Data. Table of Contents Top of page. Description. Most Recent Studies. Related Publications. Variables. National Hospital Discharge Survey Series Investigator s : National Center for Health Statistics In 1964, the National Center for Health Statistics initiated a continuous sample of hospital discharge records, collecting medical and demographic information for calculating statistics on hospital utilization, and on the nature and treatment of illness among the hospitalized population. In the surveys, which are made available in annual public use files, data are abstracted from medical records for a sample of patients discharged from a sample of nonfederal short-stay hospitals across the nation. Most Recent Studies National Hospita...
http://icpsr.umich.edu/icpsrweb/DSDR/series/43
*  Study Search Results
... Log In/Create Account Find Analyze Data. ICPSR Summer Program. Resources for Instructors. Find Analyze Data. Find Data. Filter Results skip results filters and go to search results Subject. hospitalization 8. medical care 8. Time Period to. New/updated this month 0. New/updated this quarter 0. New/updated this year 0. series: National Hospital Discharge Survey Series. Study Search Results Your query returned 8 results. Study Relevance Title A-Z Released/Updated Time Period Most Cited in ICPSR Bib. Study Title/Investigator. 1 National Hospital Discharge Survey, 2005. ICPSR 20380 United States Department of Health and Human Services. National Center for Health Statistics. 2 National Hospital Discharge Survey, 2003. ICPSR 4220 United States Department of Health and Human Services. National Center for Health Statistics. 3 National Hospital Discharge Survey, 2002. ICPSR 4166 United States Department of Health and Human Services. National Center for Health Statistics. 4 National Hospital Discharge Survey, 2007...
http://icpsr.umich.edu/icpsrweb/ICPSR/series/43/studies?q=34409&permit[0]=AVAILABLE&keyword[0]=illness&paging.startRow=1
*  National Hospital Discharge Survey, 1990
Metadata Exports. National Hospital Discharge Survey, 1990 ICPSR 6222 Principal Investigator s : United States Department of Health and Human Services. National Center for Health Statistics Summary: The National Hospital Discharge Survey NHDS collects medical and demographic information annually from a sample of hospital discharge records. more info The National Hospital Discharge Survey NHDS collects medical and demographic information annually from a sample of hospital discharge records. of Health and Human Services, National Center for Health Statistics. of Health and Human Services, National Center for Health Statistics, 1991. demographic characteristics, health care facilities, hospitalization, hospitals, illness, medical care, medical evaluation, medical procedures, medical records, patients, payment methods, treatment. Full Text Options: DOI Worldcat Google Scholar Export Options: RIS/EndNote. Full Text Options: Worldcat Google Scholar Export Options: RIS/EndNote. Hyattsville, MD: United States Departm...
http://icpsr.umich.edu/icpsrweb/ICPSR/series/43/studies/6222?sortBy=7&permit[0]=AVAILABLE&archive=ICPSR&keyword[0]=hospitals&paging.startRow=1
*  Study Search Results
... Skip to Main Content. Log In/Create Account Find Analyze Data. Membership in ICPSR. Deposit Data. ICPSR Summer Program. Resources for Instructors. Data Management Curation. Find Analyze Data. Find Data. Search/Compare Variables. Find Publications. Resources for Students. Get Help. Filter Results skip results filters and go to search results Subject. view all hospitals health care facilities 7. hospitalization 7. illness 7. medical care 7. medical evaluation 7. Data Format Delimited Online analysis 7. SAS 7. SPSS 7. Stata 7. Time Period to. Enter year as YYYY. Recency New/updated this week 0. New/updated this month 0. New/updated this quarter 0. New/updated this year 0. Export Results max. 500 Comma-delimited. MARC21 XML. series: National Hospital Discharge Survey Series. Study Search Results Your query returned 7 results. Use the search box below to revise your search, or start a new search. Results per page:. 25 50 100. Sort by:. Title A-Z Released/Updated Time Period Most Cited in ICPSR Bib. Study Titl...
http://icpsr.umich.edu/icpsrweb/ICPSR/series/43/studies?sortBy=7&dataFormat[0]=Delimited&permit[0]=AVAILABLE&archive=ICPSR&keyword[0]=hospitals&paging.startRow=1
*  L J Kozak, Centers for Disease Control and Prevention, National Center for Health Statistics - Resea
Vital and health statistics. Series 13, Data from the National Health Survey 01/2008; 165 165 :1-209. Lola Jean Kozak. Vital and health statistics. Series 13, Data from the National Health Survey 11/2006; 13 162 :1-209. Lola Jean Kozak. ABSTRACT: This report presents 2003 national estimates and trend data on the use of non-Federal short-stay hospitals in the United States. Vital and health statistics. Series 13, Data from the National Health Survey 01/2000; 13 144 :i-iv, 1-46. Owings MF, Kozak LJ: Ambulatory and inpatient procedures in the United States, 1996, National Center for Health Statistics. ABSTRACT: This report presents estimates of surgical and nonsurgical procedures performed in the United States during 1996. Estimates in this report are based on data collected from the National Hospital Discharge Survey NHDS and the National Survey of Ambulatory Surgery- NSAS. ABSTRACT: This report presents estimates of surgical and nonsurgical procedures performed in the United States during 1995. Estimates in th...
http://researchgate.net/researcher/34730949_Lola_Jean_Kozak
*  .. Information Therapy Conference .. Leave a Reply .. Comments
net-friendly docs Information Therapy Conference Information Therapy Conference. Susannah Fox. 1 Josh Seidman ‘s speech connecting our venue, the Newseum, to his mission by talking about the history of the U.S. 3 Carolyn Pare bluntly saying that we should not only look at health policy, but agriculture policy and tax policy — there are many forces at work to create this health crisis. This was especially important for me to hear since my remarks focused on Josh Seidman’s question, “Are people ready for patient-centered health IT?” The answer is yes, with an asterisk. I talked about how there are pockets of non-internet users, just as there are pockets of people who do not have a home phone. In addition to the classic low-access demographics, health status is also a significant factor in predicting internet use. If we included living with a chronic condition in the thermometer of access, that group would fall at around the 50% mark, whereas adults with no disability or chronic illness fall around the 75% m...
http://e-patients.net/archives/2008/06/information-therapy-conference.html
*  Publications Search Results
... Skip to Main Content. Toggle navigation. Search Holdings. Analyze Data Online. Publications. NIA Supported Studies. Publications 5. Journal. American Journal of Preventive Medicine 1. American Journal of Public Health 1. Cancer Causes and Control 1. Journal of Women's Health 1. Obstetrics and Gynecology 1. view all. Author. Wingo, P.A. Velebil, P. 2 Borrud, L.G. 1 Calle, E.E. 1 Cardinez, C.J. 1 Green, D.C. 1 view all. National Hospital Discharge Survey, 1988 3. National Hospital Discharge Survey, 1989 3. National Hospital Discharge Survey, 1990 3. National Hospital Discharge Survey, 1991 2. National Hospital Discharge Survey, 1992 2. view all. Export Results. RIS. EndNote XML max. Publications Search Results Your query returned 5 citations. 1996 Martin, L.M., Calle, E.E., Wingo, P.A., Heath, C.W.J. Comparison of Mammography and Pap Test Use from the 1987 and 1992 National Health Interview Surveys: Are We Closing the Gaps. American Journal of Preventive Medicine. Full Text Options: Worldcat Google Scholar...
http://icpsr.umich.edu/icpsrweb/NACDA/biblio/resources?prefix=W&collection=DATA&author[0]=Wingo, P.A.&paging.startRow=1
*  Publications Search Results
... skip to main content toggle navigation national archive of computerized data on aging search holdings analyze data online deposit data publications help nia supported studies nia funded centers filter results result type studies publications variables pub year from to author gillum b s francis c k gillum richard f view all study national hospital discharge survey national hospital discharge survey national hospital discharge survey national hospital discharge survey national hospital discharge survey national hospital discharge survey view all export results ris csv endnote xml max publications search results your query returned citations results per page sort by pub date newest title recent additions author clear all pub year citation gillum richard f gillum b s francis c k coronary revascularization and cardiac catheterization in the united states trends in racial differences journal of the american college of cardiology full text options doi worldcat google scholar export options ris endnote xml resul...
http://icpsr.umich.edu/icpsrweb/NACDA/biblio/resources?prefix=G&collection=DATA&author[0]=Gillum, B.S.&study[0]=National Hospital Discharge Survey, 1984&paging.startRow=1
*  Publications Search Results
... skip to main content toggle navigation national archive of computerized data on aging search holdings analyze data online deposit data publications help nia supported studies nia funded centers filter results result type studies publications variables pub year from to author rashidee a croft j b giles w h haldeman g a view all study national hospital discharge survey national hospital discharge survey national hospital discharge survey national hospital discharge survey national hospital discharge survey view all export results ris csv endnote xml max publications search results your query returned citations results per page sort by pub date newest title recent additions author clear all pub year citation haldeman g a croft j b giles w h rashidee a hospitalization of patients with heart failure national hospital discharge survey to american heart journal full text options doi worldcat google scholar export options ris endnote xml results contact us privacy policy connect with us...
http://icpsr.umich.edu/icpsrweb/NACDA/biblio/resources?prefix=R&collection=DATA&author[0]=Rashidee, A.&paging.startRow=1
*  Publications Search Results
... Skip to Main Content. Toggle navigation. National Archive of Computerized Data on Aging. Search Holdings. Analyze Data Online. Deposit Data. Publications. Help. NIA Supported Studies. NIA Funded Centers. Filter Results Result Type Studies 1,504. Publications 3. Variables 848,796. Pub. Year. from. to. Journal. American Journal of Epidemiology 1. Diabetes Care 1. Morbidity and Mortality Weekly Report 1. view all. Author. DeStefano, F. Ford, E.S. 3 German, R.R. 2 Newman, J.M. 2 Olson, D.R. 2 Sepe, S.J. 2 view all. Study. National Hospital Discharge Survey, 1982 2. National Hospital Discharge Survey, 1983 2. National Hospital Discharge Survey, 1984 2. National Hospital Discharge Survey, 1985 2. National Hospital Discharge Survey, 1986 2. view all. Export Results. RIS. CSV. EndNote XML max. 500. Publications Search Results Your query returned 3 citations. Results 1 - 3 Per page:. 25 50 100. Sort by:. Pub Date newest Title Recent Additions Author. 1. Clear All. Pub. Year Citation. 1991 Ford, E.S., DeStefano, F...
http://icpsr.umich.edu/icpsrweb/NACDA/biblio/resources?prefix=D&collection=DATA&author[0]=DeStefano, F.&paging.startRow=1
*  Publications Search Results
... skip to main content toggle navigation national archive of computerized data on aging search holdings analyze data online deposit data publications help nia supported studies nia funded centers filter results result type studies publications variables pub year from to author price lori l shah pinak b tahir syed m welt frederick view all study national hospital discharge survey national hospital discharge survey national hospital discharge survey national hospital discharge survey national hospital discharge survey view all export results ris csv endnote xml max publications search results your query returned citations results per page sort by pub date newest title recent additions author clear all pub year citation tahir syed m price lori l shah pinak b welt frederick eighteen year analysis of incidence mortality and cardiac procedure outcomes of acute myocardial infarction in patients years of age american journal of cardiology full text options doi worldcat google scholar export options ris endnote xml...
http://icpsr.umich.edu/icpsrweb/NACDA/biblio/resources?collection=DATA&author[0]=Price, Lori L.&paging.startRow=1
*  Publications Search Results
... skip to main content really cool minority data toggle navigation data search data browse by topic crime discrimination education employment health and well being history housing immigration minority populations african american asian latino native american political participation poverty and income public opinion race and ethnicity tools learning help about the project log in create account search for data filter results result type studies publications variables pub year from to journal inflammatory bowel diseases author inadomi john m sewell justin l yee hal f jr view all study national hospital discharge survey national hospital discharge survey national hospital discharge survey national hospital discharge survey national hospital discharge survey view all export results ris csv endnote xml max publications search results your query returned citations results per page sort by pub date newest title recent additions author clear all pub year citation sewell justin l yee hal f jr inadomi john m hospital...
http://icpsr.umich.edu/icpsrweb/RCMD/biblio/resources?collection=DATA&journal=Inflammatory Bowel Diseases
*  Publications Search Results
... skip to main content toggle navigation national archive of computerized data on aging search holdings analyze data online deposit data publications help nia supported studies nia funded centers filter results result type studies publications variables pub year from to author pleasant j c mayberry r m mcghee n jr rice r j samadi a r zaidi a a view all study national hospital discharge survey national hospital discharge survey national hospital discharge survey national hospital discharge survey national hospital discharge survey view all export results ris csv endnote xml max publications search results your query returned citations results per page sort by pub date newest title recent additions author clear all pub year citation samadi a r mayberry r m zaidi a a pleasant j c mcghee n jr rice r j maternal hypertension and associated pregnancy complications among african american and other women in the united states obstetrics and gynecology full text options doi worldcat google scholar export options ris ...
http://icpsr.umich.edu/icpsrweb/NACDA/biblio/resources?prefix=P&collection=DATA&author[0]=Pleasant, J.C.&paging.startRow=1
*  Publications Search Results
... Skip to Main Content. Toggle navigation. National Archive of Computerized Data on Aging. Search Holdings. Analyze Data Online. Deposit Data. Publications. Help. NIA Supported Studies. NIA Funded Centers. Filter Results Result Type Studies 1,504. Publications 1. Variables 848,796. Pub. Year. from. to. Author. Gillum, B.S. Gillum, Richard F. Francis, C.K. 1 view all. Study. National Hospital Discharge Survey, 1982 1. National Hospital Discharge Survey, 1983 1. National Hospital Discharge Survey, 1984 1. National Hospital Discharge Survey, 1985 1. National Hospital Discharge Survey, 1986 1. view all. Export Results. RIS. CSV. EndNote XML max. 500. Publications Search Results Your query returned 1 citations. Results 1 - 1 Per page:. 25 50 100. Sort by:. Pub Date newest Title Recent Additions Author. 1. Clear All. Pub. Year Citation. 1997 Gillum, Richard F., Gillum, B.S., Francis, C.K. Coronary revascularization and cardiac catheterization in the United States: trends in racial differences. Journal of the Ame...
http://icpsr.umich.edu/icpsrweb/NACDA/biblio/resources?prefix=G&collection=DATA&author[0]=Gillum, B.S.&author[1]=Gillum, Richard F.&paging.startRow=1
*  Publications Search Results
... Skip to Main Content. Toggle navigation. National Archive of Computerized Data on Aging. Search Holdings. Analyze Data Online. Deposit Data. Publications. Help. NIA Supported Studies. NIA Funded Centers. Filter Results Result Type Studies 1,504. Publications 1. Variables 848,796. Pub. Year. from. to. Author. Thurman, D. Guerrero, J. 1 view all. Study. National Hospital Discharge Survey, 1982 1. National Hospital Discharge Survey, 1983 1. National Hospital Discharge Survey, 1984 1. National Hospital Discharge Survey, 1985 1. National Hospital Discharge Survey, 1986 1. view all. Export Results. RIS. CSV. EndNote XML max. 500. Publications Search Results Your query returned 1 citations. Results 1 - 1 Per page:. 25 50 100. Sort by:. Pub Date newest Title Recent Additions Author. 1. Clear All. Pub. Year Citation. 1999 Thurman, D., Guerrero, J. Trends in hospitalization associated with traumatic brain injury. JAMA, The Journal of the American Medical Association. 282, 10, 954-957. Full Text Options: DOI Worldc...
http://icpsr.umich.edu/icpsrweb/NACDA/biblio/resources?prefix=T&collection=DATA&author[0]=Thurman, D.&paging.startRow=1
*  CDC - Children and Young People - Causes of Hospitalization - Data & Trends - Diabetes DDT
CDC - Children and Young People - Causes of Hospitalization - Data Trends - Diabetes DDT. Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options. For more information about this message, please visit this page: About CDC.gov. Distribution of First-Listed Diagnoses Among Hospital Discharges with Diabetes as Any Listed Diagnosis, Children and Young People 0 17 Years of Age, United States, 2009. Among hospital discharges to children and young people aged 0–17 years in 2009, about 74% had diabetes as the first-listed diagnosis. These data reflect the percentage of discharges and not the percentage of patients. Of the discharges with diabetes as the first-listed diagnosis in 2009, about 64% were for diabetic ketoacidosis. First-Listed Diagnosis ICD-9-CM Codes Number Percentage Diabetes 250 32,673 73.5. Methods and Limitations Detailed Data Table Data Source: Centers for Disease Control and Prevention CDC, data from Kids’ Inpatien...
http://cdc.gov/diabetes/statistics/hosp/kidtable1.htm
*  Technology For Doctors By Plus91 | Digital Identities for Providers and Provider Information Sour
Technology For Doctors By Plus91. Digital Identities for Providers and Provider Information Sources : Using IT to facilitate Information Therapy. C:\Healthcare\Technology\Plus91. Plus91 is a Healthcare Technology firm developing Innovative High Quality Solutions for the Indian Healthcare Industry. Digital Identities for Providers and Provider Information Sources : Using IT to facilitate Information Therapy. The simplest way to do this is to Create Websites for Doctors, Clinics and Hospitals. -- Create Directories of Providers based on Provider Information. Nrip Nihalani and. Share to Twitter. Labels: Appointment management, Doctor Websites, healthcare india, information therapy, Medical Reference Apps, Medical site Content, Medical Website Design, websitefordoctors, Websites, Websites for Doctors. Subscribe to: Post Comments Atom. Get Technology for Doctors in your Email. Plus91's Twitter Channel. Technology for Doctors. Subscribe To 'Technology for Doctors'. Over the years Plus91 has been serving a broad ran...
http://technology4doctors.blogspot.in/2011/09/digital-identities-for-providers-and.html
*  Woman's Rape, Death Spark Global Conversation on Condition of Indian Women — Charisma News
... Magazine Subscribe to Charisma Subscribe to Ministry Today. Subscribe to Charisma. Subscribe to Ministry Today. Charisma Magazine. Ministry Today. Woman's Rape, Death Spark Global Conversation on Condition of Indian Women. back to " World " Woman's Rape, Death Spark Global Conversation on Condition of Indian Women 6:00AM EST 1/3/2013. Mortality rates of Indian women in childbirth are 254 per 100,000 women, contrasted with only 21 in the United States. As a special offer, you can get 40 issues of Charisma magazine for only $40. NEW - Life in the Spirit is your Spirit-filled teaching guide. Charisma Media reserves the right to modify or remove any comment that does not comply with the above guidelines and to deny access of your Disqus account to make additional comments to the website without any notice. Charisma Media is not responsible or liable in any way for comments posted by its users. Free Gifts As a Blessing From Joyce Meyer Register now for free gifts from Joyce Meyer including an e-book, audio te...
http://charismanews.com/world/35099-womans-rape-death-spark-global-conversation-on-condition-of-indian-women
*  Publications Search Results
... Skip to Main Content. Toggle navigation. National Archive of Computerized Data on Aging. Search Holdings. Analyze Data Online. Deposit Data. Publications. Help. NIA Supported Studies. NIA Funded Centers. Filter Results Result Type Studies 1,504. Publications 2. Variables 848,796. Pub. Year. from. to. Journal. American Journal of Respiratory and Critical Care Medicine 1. Annals of Internal Medicine 1. view all. Author. Castro, Kenneth G. Agerton, Tracy 1. Bennett, Diane E. 1 Courval, Jeanne M. 1 Dooley, Samuel 1. Gibson, Judy D. 1 view all. Study. National Health and Nutrition Examination Survey NHANES, 1999-2000 1. National Hospital Discharge Survey, 1985 1. National Hospital Discharge Survey, 1986 1. National Hospital Discharge Survey, 1987 1. National Hospital Discharge Survey, 1988 1. view all. Export Results. RIS. CSV. EndNote XML max. 500. Publications Search Results Your query returned 2 citations. Results 1 - 2 Per page:. 25 50 100. Pub Date newest Title Recent Additions Author. 1. Clear All. Pub....
http://icpsr.umich.edu/icpsrweb/NACDA/biblio/resources?collection=DATA&author[0]=Castro, Kenneth G.&paging.startRow=1
*  Publications Search Results
... Skip to Main Content. Toggle navigation. National Archive of Computerized Data on Aging. Search Holdings. Analyze Data Online. Deposit Data. Publications. Help. NIA Supported Studies. NIA Funded Centers. Filter Results Result Type Studies 1,504. Publications 3. Variables 848,796. Pub. Year. from. to. Journal. Clinical Gastroenterology and Hepatology. Author. Bewtra, Meenakshi 1. Chinyu, Su 1. Lewis, James 1. Stepanova M. 1 Stepanova, Maria 1. view all. Study. National Health and Nutrition Examination Survey III, 1988-1994 2. National Hospital Discharge Survey, 1990 1. National Hospital Discharge Survey, 1991 1. National Hospital Discharge Survey, 1992 1. National Hospital Discharge Survey, 1993 1. view all. Export Results. RIS. CSV. EndNote XML max. 500. Publications Search Results Your query returned 3 citations. Results 1 - 3 Per page:. 25 50 100. Sort by:. Pub Date newest Title Recent Additions Author. 1. Clear All. Pub. Year Citation. 2010 Younossi, Zobair M., Stepanova, Maria. Hepatitis C virus infe...
http://icpsr.umich.edu/icpsrweb/NACDA/biblio/resources?collection=DATA&journal[0]=Clinical Gastroenterology and Hepatology&paging.startRow=1
*  Flashcards about Theory 160 wk1
You may also press the UP ARROW key to move the card to the "Know" box, the DOWN ARROW key to move the card to the "Don't know" box, or the RIGHT ARROW key to move the card to the Remaining box. In the outpatient setting the term first-listed diagnosis is used instead of principal diagnosis True. The first-listed diagnosis is the diagnosis that the physician lists first False. In the outpatient setting the term first-listed diagnosis is used in lieu of princiapl diagnosis True. Ross-Loos Medical Group america's oldest privately owned prepaid medical group started in Texas False. Medicare-eligible patients are not involved with HMO's or prepaid health plans False. The difference between an IPA and a PPG is that a PPG may not be owned by its member physicians whereas an IPA is physician owned False. If a primary care physician sends a patient to a specialist for consultatiion and the specialist is not in the managed care plan, the specialist may bill the primary care physician for payment True. Usually there ar...
http://studystack.com/flashcard-646864
*  CDC - Number of Discharges - Hospitalization for Heart Failure - Data & Trends - Diabetes DDT
CDC - Number of Discharges - Hospitalization for Heart Failure - Data Trends - Diabetes DDT. For more information about this message, please visit this page: About CDC.gov. Number in Thousands of Hospital Discharges with Heart Failure as First-Listed Diagnosis and Diabetes as Secondary Diagnosis, United States, 1988 2006. From 1988 to 2006, the number of hospital discharges for heart failure as first-listed diagnosis and diabetes as secondary diagnosis increased dramatically until 2003, and then the trend showed little change. The number of discharges was 187,000 in 1988, and 338,000 in 2006. Methods and Limitations Detailed Data Table Data Source: Centers for Disease Control and Prevention CDC , National Center for Health Statistics, Division of Health Care Statistics, data from the National Hospital Discharge Survey and Division of Health Interview Statistics, data from the National Health Interview Survey. Data computed by personnel in the Division of Diabetes Translation, National Center for Chronic Disea...
http://cdc.gov/diabetes/statistics/cvdhosp/hf/fig1.htm
*  CDC - Age 75+ - Causes of Hospitalization - Data & Trends - Diabetes DDT
CDC - Age 75+ - Causes of Hospitalization - Data Trends - Diabetes DDT. Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options. For more information about this message, please visit this page: About CDC.gov. Distribution of First-Listed Diagnoses Among Hospital Discharges with Diabetes as Any-Listed Diagnosis, Adults Aged 75 Years or Older, United States, 2010. First-Listed Diagnosis ICD-9-CM Codes Number in Thousands Percentage Diseases of the Circulatory System 390–459 463 30.3. Diabetes 250 111 7.3. Methods and Limitations Data Source: Centers for Disease Control and Prevention CDC, National Center for Health Statistics, Division of Health Care Statistics, data from the National Hospital Discharge Survey Data computed by personnel in CDC's Division of Diabetes Translation, National Center for Chronic Disease Prevention and Health Promotion.. Number of Persons. Detailed Tables. by Whites. by White Females. by Blacks. by Bl...
http://cdc.gov/diabetes/statistics/hosp/adult4table2.htm
*  FastStats - Anemia
... Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content. Start of Search Controls. Search Form Controls. Search The CDC Cancel. Submit Search The CDC. CDC A-Z Index. CDC A-Z. SEARCH. Start of Search Controls. Search Form Controls. Search The CDC Cancel. Submit Search The CDC. FastStats. Diseases and Conditions Anemia or Iron Deficiency. Heart Disease. Mental Health. Digestive and Liver Digestive Diseases. Oral and Dental Health. Marriage and Divorce Health Care and Insurance Access to Health Care. Ambulatory and Hospital Care. Ambulatory Care Use and Physician office visits. Emergency Department Visits. Health Expenditures. Health Insurance Coverage. Home Health Care. Suicide and Self-Inflicted Injury Life Stages and Populations Age Groups Adolescent Health. Life Expectancy Race and Ethnicity Health of American Indian or Alaska Native Population. Women s Health State and Territorial Data Reproductive Health Contraceptive...
http://cdc.gov/nchs/fastats/anemia.htm
*  CDC - Children and Young People Detailed Table - Causes of Hospitalization - Data & Trends - Diabete
CDC - Children and Young People Detailed Table - Causes of Hospitalization - Data Trends - Diabetes DDT. Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options. CDC Home CDC 24/7: Saving Lives. Protecting People. Search The CDC. Note: Javascript is disabled or is not supported by your browser. For this reason, some items on this page will be unavailable. For more information about this message, please visit this page: About CDC.gov. Diabetes Public Health Resource. Share Compartir. Distribution of Detailed Codes for Diabetes as First-Listed Diagnosis in Hospital Discharges to Children and Young People 0 17 Years of Age, United States, 2009. First-Listed Diagnosis ICD-9-CM Codes Number Percent Ketoacidosis 250.1 20,889 63.9. No mention complication 250.0 10,017 30.7. Other specified manifestations 250.8 1,005 3.1. Other diabetes codes 250.2, 250.3, 250.4, 250.5,250.6,250.7,250.9 762 2.3. Total 32,673 100.0. Methods and Limita...
http://cdc.gov/diabetes/statistics/hosp/kidtable2.htm
*  CDC - Rate per 1,000 Diabetic Population by Age, Females - Hospitalization for Heart Failure - Data
... Trends - Diabetes DDT. Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options. For more information about this message, please visit this page: About CDC.gov. Diabetes Public Health Resource. Hospital Discharge Rates for Heart Failure as First-Listed Diagnosis per 1,000 Diabetic Population Among Females, by Age, United States 1988 2006. Year 0–64 65–74 75+ Total Age-Adjusted Rate Standard Error Rate Standard Error Rate Standard Error Rate Standard Error Rate Standard Error 1988. Methods and Limitations Data Source: Centers for Disease Control and Prevention CDC , National Center for Health Statistics, Division of Health Care Statistics, data from the National Hospital Discharge Survey and Division of Health Interview Statistics, data from the National Health Interview Survey. Data computed by personnel in the Division of Diabetes Translation, National Center for Chronic Disease Prevention and Health Promotion, CDC. Numb...
http://cdc.gov/diabetes/statistics/cvdhosp/hf/table5females.htm
*  Study Search Results
... Skip to Main Content. Toggle navigation. National Archive of Computerized Data on Aging. Search Holdings. Analyze Data Online. Deposit Data. Publications. Help. NIA Supported Studies. NIA Funded Centers. Filter Results skip results filters and go to search results Result Type Studies 27. Publications 21,418. Variables 848,796. Subject. medical procedures. medical evaluation 27. illness 22. treatment 19. demographic characteristics 18. health services utilization 16. view all. Geography. United States. Boston 13. California 13. Chicago 13. Illinois 13. Inkster 13. view all. Data Format. Delimited. SAS 27. SPSS 27. Stata 27. Online analysis 12. R 8. Time Period. to. Restriction Type. Public Use 25. Restricted Use 2. Recency. New/updated this week 0. New/updated this month 0. New/updated this quarter 0. New/updated this year 1. Export Results. Comma-delimited. MARC21 XML. max. 500. Study Search Results Your query returned 5 results. Series results are grouped under the most relevant study. You can ungroup s...
http://icpsr.umich.edu/icpsrweb/NACDA/studies?keyword=medical procedures&dataFormat[0]=Delimited&permit[0]=AVAILABLE&geography[0]=United States&paging.startRow=1
*  Study Search Results
... Skip to Main Content. Toggle navigation. National Archive of Computerized Data on Aging. Search Holdings. Analyze Data Online. Deposit Data. Publications. Help. NIA Supported Studies. NIA Funded Centers. Filter Results skip results filters and go to search results Result Type Studies 60. Publications 21,417. Variables 848,796. Subject. medical procedures. treatment. medical evaluation 60. hospitalization 47. hospitals 47. medical care 47. medical records 47. view all. Geography. United States 60. Boston 13. California 13. Chicago 13. Illinois 13. view all. Data Format. SAS 32. SPSS 29. Stata 29. Delimited 19. Online analysis 18. R 6. Time Period. to. Recency. New/updated this week 0. New/updated this month 0. New/updated this quarter 0. New/updated this year 1. Export Results. Comma-delimited. MARC21 XML. max. 500. Study Search Results Your query returned 3 results. Series results are grouped under the most relevant study. You can ungroup series results. Use the search box below to revise your search, or...
http://icpsr.umich.edu/icpsrweb/NACDA/studies?keyword=medical procedures&permit[0]=AVAILABLE&keyword[1]=treatment&paging.startRow=1
*  Study Search Results
... Skip to Main Content. Toggle navigation. National Archive of Computerized Data on Aging. Search Holdings. Analyze Data Online. Deposit Data. Publications. Help. NIA Supported Studies. NIA Funded Centers. Filter Results skip results filters and go to search results Result Type Studies 27. Publications 21,415. Variables 848,796. Subject. medical procedures. hospitalization. hospitals 27. medical care 27. medical evaluation 27. medical records 27. patients 27. view all. Data Format. SAS. Online analysis 25. SPSS 24. Stata 23. Delimited 12. Time Period. from. to. Recency. New/updated this week 0. New/updated this month 0. New/updated this quarter 0. New/updated this year 0. Export Results. Comma-delimited. MARC21 XML. max. 500. Study Search Results Your query returned 2 results. Series results are grouped under the most relevant study. You can ungroup series results. Use the search box below to revise your search, or start a new search. Per page:. 25 50 100. Title A-Z Released/Updated Time Period Most Cited ...
http://icpsr.umich.edu/icpsrweb/NACDA/studies?keyword[1]=hospitalization&keyword=medical procedures&permit[0]=AVAILABLE&dataFormat[0]=SAS&paging.startRow=1
*  Study Search Results
... skip to main content log in create account find analyze data membership in icpsr deposit data icpsr summer program resources for instructors data management curation find analyze data find data search compare variables find publications resources for students get help filter results skip results filters and go to search results subject view all health care facilities hospitalization hospitals illness medical care medical evaluation data format delimited online analysis sas spss stata time period to enter year as yyyy recency new updated this week new updated this month new updated this quarter new updated this year export results max comma delimited marc xml study search results your query returned results series results are grouped under the most relevant study you can ungroup series results use the search box below to revise your search or start a new search results per page sort by study relevance title a z released updated time period most cited in icpsr bib variable relevance study title investigato...
http://icpsr.umich.edu/icpsrweb/ICPSR/studies?keyword[0]=health care facilities&q=34409&permit[0]=AVAILABLE&dataFormat[0]=Delimited&paging.startRow=1
*  Publications Search Results
... skip to main content toggle navigation national archive of computerized data on aging search holdings analyze data online deposit data publications help nia supported studies nia funded centers filter results result type studies publications variables pub year from to author johanson john f sonnenberg amnon view all study national health interview survey health interview survey national health interview survey national health interview survey national hospital discharge survey national hospital discharge survey view all export results ris csv endnote xml max publications search results your query returned citations results per page sort by pub date newest title recent additions author clear all pub year citation johanson john f sonnenberg amnon the prevalence of hemorrhoids and chronic consipation an epidemiologic study gastroenterology full text options worldcat google scholar export options ris endnote xml results contact us privacy policy connect with us...
http://icpsr.umich.edu/icpsrweb/NACDA/biblio/resources?prefix=J&collection=DATA&author[0]=Johanson, John F.&study[0]=National Health Interview Survey, 1984&paging.startRow=1
*  Publications Search Results
... Skip to Main Content. Toggle navigation. National Archive of Computerized Data on Aging. Search Holdings. Analyze Data Online. Deposit Data. Publications. Help. NIA Supported Studies. NIA Funded Centers. Filter Results Result Type Studies 1,504. Publications 1. Variables 848,796. Pub. Year. from. to. Author. Rowley, D.L. Becerra, J.E. 1 Fry, Y.W. 1 view all. Study. National Hospital Discharge Survey, 1986 1. National Hospital Discharge Survey, 1987 1. view all. Export Results. RIS. CSV. EndNote XML max. 500. Publications Search Results Your query returned 1 citations. Results 1 - 1 Per page:. 25 50 100. Sort by:. Pub Date newest Title Recent Additions Author. 1. Clear All. Pub. Year Citation. 1991 Becerra, J.E., Fry, Y.W., Rowley, D.L. Morbidity estimates of conditions originating in the perinatal period: United States, 1986 through 1987. Pediatrics. 88, 3, 553-559. Full Text Options: Worldcat Google Scholar Export Options: RIS EndNote XML. Results 1 - 1. 1. contact us. privacy policy Connect with us:....
http://icpsr.umich.edu/icpsrweb/NACDA/biblio/resources?collection=DATA&author[0]=Rowley, D.L.&paging.startRow=1
*  90mm Hexanon for KO - $40
03-10-2010, 12:59 PM mgb74 1 Attachment s 90mm Hexanon for KO - $40 90mm f3.5 Hexanon for Koni Omega Rapid, etc. Glass is very good, cosmetics good. $40 plus actual shipping from 55441 in US 16 oz. 03-10-2010, 01:03 PM artbyalina Price seems unright Quote: Originally Posted by mgb74. 90mm f3.5 Hexanon for Koni Omega Rapid, etc. Glass is very good, cosmetics good. $40 plus actual shipping from 55441 in US 16 oz. I believe there are three lenses on ebay right now for half that price. The only one I see on EBay has fungus and the shutter looks completely broken. 03-10-2010, 01:29 PM TheFlyingCamera Folks- as a general rule of politeness in these forums, if you see something for sale and you don't like the price, just like in a regular store, move along without comment. 03-10-2010, 01:32 PM mgb74 Quote: Originally Posted by artbyalina. I believe there are three lenses on ebay right now for half that price. I only see 2 searching on 90mm hexanon, 90mm rapid, 90mm koni, and 90mm omega. Do you mean the one for $35 t...
http://apug.org/forums/classifieds-sale/print-73718-90mm-hexanon-ko-40-a.html
*  Template:Infobox body process/doc
template infobox body process doc template infobox body process doc this infobox is intended to be used for normal bodily processes this infobox is not intended for diseases or disorders but can be used for bodily responses to diseases or disorders name name of process image image of process caption description of image organisms organism that can perform the process biological system main biological system involved health health effects of the process beneficial the process befits the organism harmful the process harms the organism unaffected the process does not benefit nor harm the organism variable the process depends on conditions of the organism action the control of the process voluntary the process initiated consciously by the organism involuntary the process initiated unconsciously by the organism voluntary and involuntary the process can be initiated consciously or unconsciously by the organism stimuli cause s that can provokes the process to occur ex pain hormones discomfort pleasure irritation str...
https://en.wikipedia.org/wiki/Template:Infobox_body_process/doc
*  .. FDA DEMANDING EVALUATION OF 23ANDME GENOME-TESTING KIT
fda demanding evaluation of andme genome testing kit november by cielitolynn leave a comment on november th joel hruska authored an article in extremetech entitled fda suspicious of andme genome testing kit demands evaluation reporting that as of november the fda has brought andme activities to a halt andme is now prohibited from selling any of its dna analysis kits until it receives fda authorization for the device the fda took action to block andme after years of allowing the product to be sold because according to a letter andme has increased the number of claims it makes for its product regarding the total number of genetic factors it can analyze and the conditions it detects â but it has failed to submit proof of the efficacy of its detection methods or the error rate the article indicates that in andmeâ claimed to testâ carrier status for conditions drug responses disease risks and specific traits today andme claims to test carrier status on conditions drug responses disease risks and specific traits th...
http://parkinsonsresource.org/featured-posts/fda-demanding-evaluation-of-23andme-genome-testing-kit/
*  John Killaly
... 'John Killaly' 1776 1832 was the most significant Irish canal engineer working originally for the Grand Canal company and later, as an engineer, under the 'Directors-General of Inland Navigation'. For the extension from Tullamore to Shannon Harbour another bog had to be crossed near the river Brosna, and this time Killaly carried out extensive drainage works over several years along the line of the canal and allowed the land to subside before excavating the canal. 3 By this time he had become the company's chief with a salary of around £800. On the opening of the canal in 1803 he became an engineer under the Directors-General of Inland Navigation, whilst still receiving a reduced salary from the Grand Canal company until 1810. He surveyed an extension to the Royal Canal to Lough Allen but by this time the Royal Canal Co was in financial trouble and was declared bankrupt in 1813, leaving the Directors-General to complete the line to the Shannon. In 1823, he was asked to re-examine his plans for an extensi...
https://en.wikipedia.org/wiki/John_Killaly
*  Post #1395584
... 09-17-2012 11:20 PM. #0. John Nikon F. Join Date Apr 2008 Location Duvall, WA, USA Shooter 35mm Posts 1,567. The 35/2 Nikkor-O is much sought after by the m4/3rds crowd. I was kinda surprised to get my current copy for $65 or so. Granted, it was non-AI, but I did have a beater that had the AI ring on it. Six screws on each lens, and the rings were swapped. KEH usually has them for about $100-$130, depending on condition. Note: the O was never an AI lens, so, it'll be either a milled AI'd lens, or a factory AI'd lens, even if KEH or eBay sellers call it an AI lens. The AI/AIS lenses usually run another $60-$70 over the O lens, btw. -J. APUG: F3P, F2AS, FM2n DPUG: D2x Nikkors: 18-70/3.5-4.5G AF-S DX f/D2x, 20/3.5 UD, 24/2 AI, 35/2 O, 50/1.4 S, 85/1.8 K, 105/4 Micro AIS My FB - My flickr stream My SmugMug. Adv Reply. Reply w/quote....
http://apug.org/forums/viewpost.php?p=1395584
*  J. Pharmacol. & Exper. Therapeutics
j pharmacol exper therapeutics j pharmacol exper therapeutics redirect journal of pharmacology and experimental therapeutics...
https://en.wikipedia.org/wiki/J._Pharmacol._&_Exper._Therapeutics
*  J Pharmacol & Exper Therapeutics
j pharmacol exper therapeutics j pharmacol exper therapeutics redirect journal of pharmacology and experimental therapeutics...
https://en.wikipedia.org/wiki/J_Pharmacol_&_Exper_Therapeutics
*  ARYx Therapeutics, Inc.
aryx therapeutics inc aryx therapeutics inc redirect aryx therapeutics...
https://en.wikipedia.org/wiki/ARYx_Therapeutics,_Inc.
*  Cannasat Therapeutics
... redirect cynapsus therapeutics...
https://en.wikipedia.org/wiki/Cannasat_Therapeutics
*  Cynapsus Therapeutics Inc.
cynapsus therapeutics inc cynapsus therapeutics inc redirect cynapsus therapeutics...
https://en.wikipedia.org/wiki/Cynapsus_Therapeutics_Inc.
*  Cytori Therapeutics, Inc.
cytori therapeutics inc cytori therapeutics inc redirect cytori therapeutics...
https://en.wikipedia.org/wiki/Cytori_Therapeutics,_Inc.
*  Edge Therapeutics, Inc.
edge therapeutics inc edge therapeutics inc redirect edge therapeutics...
https://en.wikipedia.org/wiki/Edge_Therapeutics,_Inc.
*  Goodman & Gillman's The Pharmacological Basis of Therapeutics
goodman gillman s the pharmacological basis of therapeutics goodman gillman s the pharmacological basis of therapeutics redirect goodman gilman s the pharmacological basis of therapeutics...
https://en.wikipedia.org/wiki/Goodman_&_Gillman's_The_Pharmacological_Basis_of_Therapeutics
*  Regulus Therapeutics Inc
... redirect regulus therapeutics...
https://en.wikipedia.org/wiki/Regulus_Therapeutics_Inc
*  Regulus Therapeutics Inc.
regulus therapeutics inc regulus therapeutics inc redirect regulus therapeutics...
https://en.wikipedia.org/wiki/Regulus_Therapeutics_Inc.
*  Sarepta Therapeutics, Inc.
sarepta therapeutics inc sarepta therapeutics inc redirect sarepta therapeutics...
https://en.wikipedia.org/wiki/Sarepta_Therapeutics,_Inc.
*  The Pharmacological Basis of Therapeutics
... redirect goodman gilman s the pharmacological basis of therapeutics...
https://en.wikipedia.org/wiki/The_Pharmacological_Basis_of_Therapeutics
*  Astex Therapeutics
... redirect astex...
https://en.wikipedia.org/wiki/Astex_Therapeutics
*  Ember Therapeutics
... redirect fndc...
https://en.wikipedia.org/wiki/Ember_Therapeutics
*  Kenwood therapeutics
... redirect bradley pharmaceuticals...
https://en.wikipedia.org/wiki/Kenwood_therapeutics
*  Manipulative Therapeutics
... redirect joint manipulation...
https://en.wikipedia.org/wiki/Manipulative_Therapeutics
*  Targeted therapeutics
... redirect targeted therapy...
https://en.wikipedia.org/wiki/Targeted_therapeutics
*  Therapeutics
... redirect therapy...
https://en.wikipedia.org/wiki/Therapeutics
*  ARYx
... redirect aryx therapeutics...
https://en.wikipedia.org/wiki/ARYx
*  NeuGene
... redirect sarepta therapeutics...
https://en.wikipedia.org/wiki/NeuGene
*  Pharmacy & Therapeutics Committee — Medical Center Public Site
Pharmacy Therapeutics Committee — Medical Center Public Site. Patient Services Medical Center Physicians Group Claude Moore Library School of Nursing School of Medicine UVA. 434.924.3627. Medical Center. Skip to content. Skip to navigation. Personal tools Log in portlets: header portlets: footer. Navigation Departments Services. People. Knowledgelink. Search. Home. Clinical Staff Office. csec. Pharmacy Therapeutics Committee. Info. Pharmacy Therapeutics Committee. Contacts. Administration: Michelle McCarthy, PharmD Co-Chairs: John Densmore, MD and Rafael Saenz, PharmD. Charge. The Pharmacy and Therapeutics Subcommittee is an interdisciplinary committee charged with the institutional oversight of the use of pharmaceutical and other therapeutic products. This Committee reports to the Clinical Staff Executive Committee and is authorized to develop and maintain a Medical Center formulary that is financially responsible and clinically effective. Membership: Includes the Director of Pharmacy and representation from...
http://medicalcenter.virginia.edu/clinicalstaff/csec/pharmacy.html
*  GRP-106 Involvement of the Pharmacy and Therapeutics Committee in Clinical Decision Support System
... s Focused on Anticoagulants -- Touleimat et al. 20 Suppl 1 : A38 -- European Journal of Hospital Pharmacy: Science and Practice. Search this site. Online First. Current issue. About the journal. Subscribe. Online First. Current issue. GRP-106 Involvement of the Pharmacy and Therapeutics Committee in Clinical Decision Support Systems Focused on Anticoagulants M Touleimat., N Borgnis-Desbordes. Brest University Hospital, Pharmacy, Brest, France. About ten meetings with clinicians cardiologists, thrombosis specialists and pharmacists from the Pharmacy and Therapeutics Committee PTC were required to write these CDSSs. The final CDSSs were validated by the Pharmacy and Therapeutics Committee PTC. Results Nine CDSSs had already been validated by the PTC: Vitamin K Antagonist VKA, heparin sodium, heparin calcium, Low Molecular Weight Heparins LMWHs in prophylactic and curative treatment of deep-vein thrombosis and pulmonary embolism, LMWHs for acute coronary syndrome ST-segment elevation myocardial infarction an...
http://ejhp.bmj.com/content/20/Suppl_1/A38.2.abstract
*  Medicaid Pharmacy and Therapeutics Committee - New York State Department of Health
... Your browser does not support iFrames. Department of Health. Information for a Healthy New York. Medicaid. Medicaid Home. Managed Care. Child Health Plus. Family Planning Benefit Program. Health Homes. Medicaid EHR Incentive. Local Departments of Social Services. Medicaid Medicare Part D. Prescription Drug Prices. Medicaid Administrative Law Judges ALJ Decisions. Medicaid Update. Medicaid Quality and Evaluation. eMedNY Website. Program Information. Medicaid PCRI. Reference Guides. Rates. Notice of Privacy Practices. Search. Search this site:. Health Insurance Programs. Employment Opportunities. Community, Family Minority Health. Health Care Professionals Patient Safety. Hospitals, Nursing Homes, Home Care, Hospice Other Health Care Facilities. Health Safety in the Home, Workplace Outdoors. Healthy Lifestyles Prevention. Laws Regulations. Meetings Training. Grants/Funding Opportunities. Health Information Technology Health IT. Freedom of Information Law. Related Sites. Medicaid Pharmacy and Therapeutics C...
http://health.ny.gov/health_care/medicaid/program/ptcommittee/meetings/2006/index.htm
*  Medicaid Pharmacy and Therapeutics Committee
... Agenda for April 29, 2010. Medicaid Pharmacy and Therapeutics Committee Agenda for April 29, 2010. The Pharmacy Therapeutics P T Committee will meet April 29, 2010, from 8:30 a.m. Description: The Committee will review the following therapeutic classes for Preferred Drug Program inclusion and recommend preferred and non-preferred status. Drugs Affected: Fortamet metformin HCl ER, Glucophage metformin HCl, Glucophage XR metformin HCl ER, Glumetza metformin HCl ER, metformin HCl, metformin HCl ER, Riomet solution metformin HCl. C Preferred Drug Program: Re-review. The Committee will review new clinical and financial information as required, to recommend preferred and non-preferred drugs. Drugs Affected: Avelox moxifloxacin, ciprofloxacin, ciprofloxacin ER, Cipro ciprofloxacin, Cipro XR ciprofloxacin ER, Factive gemifloxacin, Levaquin levofloxacin, Noroxin norfloxacin, ofloxacin, Proquin XR ciprofloxacin. Drugs Affected: Cetraxal ciprofloxacin, Cipro HC ciprofloxacin/hydrocortisone, Ciprodex ciprofloxacin/d...
http://health.ny.gov/health_care/medicaid/program/ptcommittee/meetings/2010/04/ptagenda04-29-10.htm
*  National Pharmacy & Therapeutics Committee | Indian Health Service (IHS)
National Pharmacy & Therapeutics Committee. Indian Health Service IHS. Skip to site content. U.S. Department of Health and Human Services. Indian Health Service The Federal Health Program for American Indians and Alaska Natives. Feedback. Employee Resources. A to Z Index. A to Z Index. Select a letter to view all IHS.gov websites with names beginning in that letter. A B. C. D. E. F. G H. I. J. K. L. M N. O. P. Q R. S T. U. V. W. X Y Z # Search. Home. About IHS. Agency Overview. Annual Budget. Eligibility. Event Calendar. Indian Health Manual. Key Leaders. Legislation. Organizational Structure. Our Employees. Locations. Headquarters. Alaska Area. Albuquerque Area. Bemidji Area. Billings Area. California Area. Great Plains Area. Nashville Area. Navajo Area. Oklahoma City Area. Phoenix Area. Portland Area. Tucson Area. for Patients. Affordable Care Act ACA. Contract Health Services CHS. Find Health Care. Frequently Asked Questions. Health Care. Health Topics. Improve Your Health. Patient Forms. Patients Rights &...
http://ihs.gov/nptc/index.cfm?module=dsp_nptc_links
*  Drug and Therapeutics Committees - A Practical Guide: 6.Tools to investigate the use of medicines: 6
... 5 Drug use evaluation DUE drug utilization review. drug use evaluation Keywords. formulary - process Keywords. selection of medicines. 6.5 Drug use evaluation DUE drug utilization review. Annex 6.2 DUE criteria on data collection form for amikacin. Drug use studies using aggregate data or health facility indicators may indicate that there is over- or under-consumption of medicines, and qualitative studies may indicate why certain health staff and patients behave the way they do. • uses: appropriate indication for drug, absence of contraindications • selection: appropriate drug for clinical condition • dosing: indication-specific dosing, intervals and duration of treatment • interactions: absence of interactions - drug-drug, drug-food, drug-laboratory • preparation: steps involved with preparing a drug for administration • administration: steps involved in administration, quantity dispensed • patient education: drug and disease-specific instructions given to patients • monitoring: clinical and laboratory •...
http://apps.who.int/medicinedocs/en/d/Js4882e/8.5.html
*  Pharmacy and Therapeutics Committee — Office of Faculty Affairs
... UNC School of Medicine. UNC Chapel Hill. UNC Health Care. Popular Links. UNC Directory. Maps Directions. Health Sciences Library. Webmail. IT Support. Make a Gift. Find a Doctor. Calendar. Careers. . Log in. Office of Faculty Affairs. Navigation. Faculty Resources. Faculty Handbook. All Faculty Resources. Office of Faculty Affairs. Policies. Research Resources. Teaching Resources. Clinical Resources. Clinicians Updates. 2011. MSEC. 2011 Spring Semi-Annual Medical Staff Meeting. MSEC Semi-Annual Medical Staff Meeting Spring 2010. Awards Distinguished Professorships. Professional Development. Promotion and Tenure. Academy of Educators. Program in Leadership Development. Association of Professional Women in Medicine APWIMS. "Building Interdisciplinary Research Careers in Women’s Health” BIRCWH. KL2. APT Presentations. ACCLAIM 2012-13 Graduation Photos. ACCLAIMdsc 3102.JPG. ACCLAIMdsc 3108.JPG. ACCLAIMdsc 3111.JPG. ACCLAIMdsc 3112.JPG. ACCLAIMdsc 3115.JPG. ACCLAIMdsc 3116.JPG. ACCLAIMdsc 3124.JPG. ACCLAIMdsc...
https://med.unc.edu/facultyaffairs/faculty-resources/clinical-resources-1/msec/msec-semi-annual-medical-staff-meeting-spring-2010/Pharmacy and Therapeutics Committee.pdf/view
*  Pharmacy & Therapeutics Committee
Anti-Allergens, Oral Antihistamines, Minimally Sedating Botulinum Toxins Epinephrine, Self-injected Cough and Cold Intranasal Rhinitis Bronchodilators, Beta Agonist Glucocorticoids, Inhaled Leukotriene Modifiers COPD Agents Smoking Cessation Immunomodulators, Atopic Dermatitis Immune Globulins Cytokine/CAM Agents Hemophilia Ophthalmic Antibiotics Ophthalmic Antibiotic/Steroid Combinations Ophthalmic Antiinflammatories Ophthalmics for Allergic Conjunctivitis Ophthalmics, Glaucoma Agents. *The P T Committee will make its recommendations for these classes immediately following each drug class review. Recommendations will be posted on this Web site by 5 p.m. The Department's final PDL decisions for these classes will not be made until financial reviews are done by department staff and PDL decisions approved by the Health and Welfare Director following the May meeting. **The P T Committee will make its recommendations for these classes immediately following each drug class review. The Department's final PDL decisi...
http://healthandwelfare.idaho.gov/Medical/PrescriptionDrugs/PTCommittee/tabid/207/Default.aspx
*  P&T Committee | Pharmacy Program
P T Committee. Pharmacy Program. Jump to navigation Utah.gov Services. Agencies. Utah Department of Health. Home. Health Services. A-Z List. FAQ. Data. About Us. Search all of Utah.gov. Utah.gov Search Text Box. Submit your search. Medicaid From A-Z | Contact Us | Español. Medicaid Home. Apply for Medicaid. Apply for Medicaid English Cómo y Dónde Pedir la Asistencia Médica. Medical Programs. Medical Assistance Programs Traditional and Non-Traditional Medicaid Summary of All Medicaid Programs Spenddown Program Medically Needy Medicaid Long-Term Care and Waiver Programs Autism Waiver Program Buyout Program Children's Health Insurance Program Utah's Premium Partnership for Health Insurance Baby Your Baby Primary Care Network Programs for Enrolled Medicaid Members Children's Health/Evaluation Care CHEC Restriction Program Tobacco Cessation Program Living Well with Chronic Conditions Program. Medicaid Members. Programs and Services Resources Providers Additional Information. Health Care Providers. Become a Medicai...
https://medicaid.utah.gov/pharmacy/pt-committee?p=Criteria%20Review%20Documents/H2%20Antagonist%20(March%202012)/
*  .. Pharmacy and Therapeutic Committee Updates 2014 .. Search the Blog .. Contact a
« Home. Search the Blog. Loading. ED Call Master Orientation. Medical Library. News You Can Use. Meetings CMEs. Online CMEs. Bylaws and Rules Pharmacy Updates Publications Research Institute Resources Scholarly Activities. Tools. Oncology Order Sets. Contact a Colleague. Search for Medical Staff by Last Name:. Join the AAMC Medical Staff Weekly. Print this Page. Pharmacy and Therapeutic Committee Updates 2014. Pharmacy and Therapeutics Committee 2014 Updates. December 2015 No Meeting November 2015 October 2015 September 2015 August 2015 July 2014 June 2014 May 2014 April 2014 March 2014 February 2014 January 2014. . Click link to access older update:. Pharmacy and Therapeutics Committee 2013 Updates....
http://aahs.org/medstaff/?page_id=3277
*  Post Graduate Year 2 | Children's Hospital of Wisconsin
Post Graduate Year 2. Children's Hospital of Wisconsin. For medical professionals. Medical care. Find a doctor. Children's Hospital locations Milwaukee hospital. Find a doctor. Find information for medical professionals. For medical professionals. In this section Pharmacy Residency program Pharmacy overview Post graduate year 1 Post graduate year 2 Application process PGY2. For medical professionals. Pharmacy Residency program. Post graduate year 2 Post graduate year 2 Children's Hospital of Wisconsin PGY-2 pharmacy residency program provides pharmacy residents with opportunities to participate in multidisciplinary health care rounds in all acute care rotations as well as work with attending physicians, pediatric medical residents, pharmacy and medical students, nurses and pharmacists. The PGY-2 pharmacy resident receives an appointment to the Pharmacy and Therapeutics Committee, Medication Safety Committee and Pharmacy Clinical Practice Council. In addition, the resident will have the opportunity to ...
http://chw.org/medical-professionals/education/pharmacy-residency/post-graduate-year-2/
*  Welcome to the Committee on Open Government
... Your browser does not support iFrames. State of New York Department of State Committee on Open Government One Commerce Plaza 99 Washington Ave. Albany, New York 12231 518 474-2518 Fax 518 474-1927 http://www.dos.ny.gov/coog/. July 19, 2002 The staff of the Committee on Open Government is authorized to issue advisory opinions. The ensuing staff advisory opinion is based solely upon the information presented in your correspondence. Dear I have received your letter of July 3, as well as the materials attached to it. You have sought an advisory opinion concerning the status of the Pharmacy Therapeutics Committee the Committee, an entity created by the State Department of Health, under the Open Meetings Law. According to your letter, the Department in the 2001 Executive Budget proposed to statutorily create a P T Committee, but that aspect of the budget was rejected by the State Legislature. Following the rejection by the Legislature, the Department created the Committee as a completely internal mechanism, re...
http://docs.dos.ny.gov/coog/otext/3492.htm
*  OhioBWC - Provider - Service: Forms
... State Agencies. Online Services. HOME WORKERS. Change my address. Check benefits status. Check claim status. View claim documents. Who is my CSS. EMPLOYERS. Coverage look-up. Dates to remember. Make payment. Program eligibility look-up. Reprint certificate of coverage. Update policy demographics. SAFETY SERVICES. Request consulting services. Training center. Safety grants. Safety councils. Wellness grants. MEDICAL PROVIDERS. View claim documents. Drug formulary look-up. Billing and reimbursement manual. Medical dispute management. Medical bill payment look-up. BWC LIBRARY. Annual report. Publications. Policies. Rules, statutes and executive orders. Safety & Hygiene library services. CONTACT US. Accident/Injury Info. Claim Info. Claim Reference Info. Communications profile. Look-Ups. Resources. Services. Forms. Section Map. Online support available Monday through Friday 8 a.m. - 5 p.m. Click here to get help. OhioBWC - Provider - Service: Forms. Forms for pharmacy benefits. Request for Prior Authorization...
https://bwc.ohio.gov/provider/services/PharmacyBenefits/Forms.asp
*  JGH - Our Services: Pharmacy
... 122 Pinnell Street, PO Box 720, Ripley, WV 25271. HELP ME FIND OUR PROVIDERS OUR SERVICES FOR PATIENTS FOR VISITORS. General Surgery. The Department of Pharmacy, consistent with the mission of Jackson General Hospital, places a priority on providing high quality pharmaceutical care to patients in a safe and efficient manner. Pharmacy services are provided to Jackson General Hospital patients by a staff of two pharmacists and three pharmacy technicians. Pharmacists offer on-call clinical services 24 hours a day to assist the multidisciplinary healthcare team in optimizing pharmaceutical care of the patients. Patient medication distribution is provided by a secure computerized medication management, ServeRX, designed to enhance patient safety and improve medication management. The many contributions made by our pharmacist and pharmacy technicians in providing patient medication services include:. Procurement, distribution, and control of drug products used in the hospital Drug order review Monitoring drug ...
http://jacksongeneral.com/our-services---pharmacy.php
*  Pharmacy Services Evidence Based Reports - Pharmaceutical
... Oregon.Gov. Text Size: A+ A- A. Text Only. . Translate. Spanish. Chinese. French. German. Italian. Japanese. Russian. Thai. More Languages ». Select Language. Find. Pharmacy Services. About Us. Contact Us. Frequently Asked Questions. Medicaid Prescription Coverage. Preferred Drug List. Evidence Based Reports Currently selected. Pharmacy Reimbursement AAAC. Prescription Drug Abuse. Monitoring Program. Commissions/Committees. Oregon Prescription Drug Program. Oregon Health Authority. . Evidence Based Reports - Pharmaceutical. Article Content. These studies are the work of the Health Resources Commission. The commission was eliminated by the 2011 Legislature and replaced by the Pharmacy and Therapeutics Committee. About Us. Appointed Members. PT Board Meetings. A. B. C. D. E. F. G. H. I. L. M. N. O. P. S. T. U....
http://oregon.gov/oha/pharmacy/Pages/evidence-based-reports.aspx
*  Lloyd Bennett, MD
lloyd bennett md find a physician events news about us contact us physician careers insurances accepted find us on facebook home lloyd bennett md hospitalist dr lloyd bennett is board certified by the american board of internal medicine he earned his bachelor of arts in chemistry and zoology from miami university in oxford oh his doctor of medicine was earned from the university of rochester school of medicine and dentistry in rochester ny his internship and residency in internal medicine was completed at strong memorial hospital primary care program in rochester ny dr bennett most recently worked as a staff physician with james a haley veterans hospital in tampa fl and brevard va outpatient center in viera fl while there he served as chairman of the continuous quality improvement committee and was responsible for identifying areas for improvement and implementing system wide change he also served as chairman of the pharmacy and therapeutics committee and was responsible for development and maintenance of loc...
http://health-first.org/physician/physicians/bennett_lloyd/index.cfm
*  CHAPTER 319v MEDICAL ASSISTANCE
... Table of Contents Sec. d to make ten and one-half per cent increase applicable to rate period beginning July 1, 2000, and effective June 1, 2001, and amended Subsec. d to provide that outpatient rates in effect as of June 30, 2003, shall remain in effect through June 30, 2005, and amended Subsec. Return to Chapter Table of Contents Return to List of Chapters Return to List of Titles. Return to Chapter Table of Contents Return to List of Chapters Return to List of Titles. The Department of Social Services, upon entering into a contract for the provision of prescription drug coverage to medical assistance recipients receiving services in a managed care setting as provided by section 17b-266a, shall in consultation with the Pharmaceutical and Therapeutics Committee, expand the preferred drug list for use in the HUSKY Plan, Part A and Part B. e to require Department of Social Services to adopt preferred drug list on or before July 1, 2003, to replace provision re department's adoption of preferred drug list ...
https://cga.ct.gov/2006/sup/Chap319v.htm
*  Alain Mita, MD - Cedars-Sinai
... Follow us: Follow Us on Twitter Like Us on Facebook Follow Us on Google+ Watch videos on our Youtube channel. Find a Doctor. Main Menu. Search. More Contact Us. Locations & Directions. Medical Staff Directory. Careers. Giving. International Patients. A A A. Find a Doctor. Conditions Treatments. Programs & Services. Patients Visitors Guide. For Medical Professionals. Research. Education. Home. Research. Faculty Directory. Alain Mita, MD. Alain Mita, MD. Share Email Print. Co-Director, Experimental Therapeutics Program. Alain Catalin Mita, MD, is co-director of the Experimental Therapeutics Program at the Samuel Oschin Comprehensive Cancer Institute. He is also a member of the multidisciplinary thoracic and head and neck clinics at the cancer institute. Dr. Mita's research focuses on the development of early clinical trials of novel therapeutic agents. His clinical focus is in medical oncology and experimental cancer therapies. He served as a principal investigator for more than 40 Phase I clinical tri...
http://cedars-sinai.edu/Research/Faculty-Directory/Bios/Alain-Mita-MD.aspx
*  Minutes 12.02.99 School of Medicine at the University of Virginia
... Patient Care. Medical Center. Physicians Group. UVA HEALTH SYSTEM. Claude Moore Library. School of Nursing. School of Medicine. Skip to content. Skip to navigation. Medicine. Education. Research. Departments. Community. Minutes 12.02.99. Undergraduate Medical Education. Curriculum Committee. Curriculum Committee Members. Curriculum Committee Minutes. Minutes 12.02.99. Curriculum Policies and Procedures. Curriculum Committee Governance Document. Pre-Clerkship Leadership Community. Clerkship/PostClerkship Committee. Content Thread Leaders. NxGen Curriculum. Faculty Development NxGen Curriculum. Common Elements of the NxGen Curriculum. Reports. Faculty Financial Disclosure. SOM Home. Education. Undergraduate Medical Education. Curriculum Committee. Curriculum Committee Minutes. Minutes 12.02.99. Info. Minutes 12.02.99. University of Virginia School of Medicine Curriculum Committee Minutes 12.02.99 Pediatric Pathology Conference Room, 4:00 p.m. Present underlined were: Reid Adams, Robert Bloodgood, Anita Cla...
http://medicine.virginia.edu/education/medical-students/UMEd/curriculum/minutes/120299-page
*  Conducting Clinical Research by Judy Stone, MD: About the Author
Conducting Clinical Research by Judy Stone, MD: About the Author. Testimonials. Buy the Book ----. Table of Contents. Sample Chapter. Forms and Worksheets. About the Author. Appearances. Recommended Reading. News Tips. Contact Us. Email Newsletter. Scientific American Dr. Stone is now a guest blogger for Scientific American. You can find her column at: Molecules to Medicine. Read More Free Newsletter Subscribe to our free email newsletter: Email Address. About the Author: Judy Stone. Judy Stone, MD, is an infectious disease specialist who is Board Certified in Internal Medicine. In addition to her active clinical practice, Dr. Stone has had considerable experience attracting and successfully conducting numerous Phase 2 and 3 clinical trials for a variety of infectious disease indications over more than 20 years. She also is a speaker on antibiotics and infectious diseases. Dr. Stone is a graduate of Washington University in St. She completed medical school at the University of Maryland, residency at Rochester...
http://conductingclinicalresearch.com/about_the_author.php
*  ACP-ASIM Observer, December 2001 - Drug shortages raise new fears about patient care
ACP Internist Search ACP Internist. Drug shortages raise new fears about patient care As supply problems force physicians to substitute drugs, some worry about the risk of mistakes. Problems with flu vaccine supplies: déjà vu all over again. FDA's Drug Shortages page American Society of Health-System Pharmacists drug shortages information Proactive guidelines to safely manage scarce supplies Drug shortages become a worry at hospitals around the country. Shortages can be a nuisance for physicians, who get disrupted by calls from pharmacists or patients looking for a suitable alternative. See "Problems with flu vaccine supplies: déjà vu all over again?" below. One problem is that no one including the FDA is in charge of managing drug shortages, nor is there any early warning system to let physicians and pharmacists know that a drug may soon be scarce. Tyler said, "but that's in essence what we're doing." Getting the word out as early as possible to physicians and to pharmacy and therapeutics committees allows t...
http://acpinternist.org/archives/2001/12/drug_shortage.htm
*  LIT Instructions for new CC Designation
Indiana University South Bend Indiana University South Bend IU South Bend. Fall 2014 Common Core Course Offerings. 2014-2015 Senate General Education Committee Members. Course approval docs LIT Instructions for new CC Designation Common Core: Literary and Intellectual Traditions. New LIT Variable Title Requiring a New Common Core Course Designation - Instructions. The following LIT course designations are approved for use on the IU South Bend campus:. Step One : CARMin New Course Approval Process. In preparing the CARMin form for a new common core course, please answer the questions below with the following: CARMin question 5a. Course title: Literary and Intellectual Traditions. 4.Upon approval on this campus unit curriculum committee, unit dean, Senate General Education Committee, Senate Curriculum Committee, VCAA s Office, the proposal is submitted for remonstrance for at least a 30 day period, before final approval for the new course is complete. Because the process for getting new course approval can take...
https://iusb.edu/general-educ/course-approval-docs/LIT-Instructions-New-CC-Designation.php
*  .. On Tap in the Capitol, June 21
comments on tap in the capitol june by the news service of florida friday june experts discuss school safety a panel of experts will discuss the future of school safety during the summer conference of the florida association of school administrators the panel moderated by state sen bill montford will include speakers from the fbi the national association of secondary school principals and the jefferson county schools in colorado also it will include state rep greg steube a sarasota republican who sponsored a school safety bill this year a m grand hyatt tampa bay bayport dr tampa unemployment numbers released the state will release unemployment numbers for may a m medicaid drugs at issue the agency for health care administration s pharmaceutical and therapeutics committee will meet to discuss drugs recommended for a preferred drug list p m tampa airport marriott tampa international airport scott gov rick scott does not have any public events on his schedule â campaigns â rich at tampa tiger bay former sen nan ...
http://politics.heraldtribune.com/2013/06/21/on-tap-in-the-capitol-june-21-2/
*  Minutes 11.29.12 School of Medicine at the University of Virginia
... Patient Care. Medical Center. Physicians Group. UVA HEALTH SYSTEM. Claude Moore Library. School of Nursing. School of Medicine. Skip to content. Skip to navigation. Medicine. Education. Community. Minutes 11.29.12. Undergraduate Medical Education. Curriculum Committee. Curriculum Committee Members. Curriculum Committee Minutes. Minutes 11.29.12. Curriculum Policies and Procedures. Curriculum Committee Governance Document. Pre-Clerkship Leadership Community. Clerkship/PostClerkship Committee. NxGen Curriculum. Faculty Development NxGen Curriculum. Common Elements of the NxGen Curriculum. Education. Undergraduate Medical Education. Curriculum Committee. Curriculum Committee Minutes. Minutes 11.29.12. Minutes 11.29.12. University of Virginia School of Medicine Curriculum Committee Executive Management Group Minutes – 11/29/12. Patient Centered Medical Home Curriculum PCMH. Evan Heald. Six Principles of PCMH - Personal physician - Whole person orientation - Coordination of care across settings - Quality Safe...
http://medicine.virginia.edu/education/medical-students/UMEd/curriculum/minutes/minutes-11-29.12.html
*  GCC-Agenda-April-15-2009
Graduate Curriculum Committee. HELP - marked catalog copy. Useful Links Graduate Council Council for Teacher Education Graduate School Office of Academic Program Planning and Development Service Learning Committee University Catalogs Writing Across the Curriculum Committee Educational Policies and Planning Committee. Graduate Curriculum Committee GCC Agenda April 15, 2009 - 3:30 p.m. Memorandum of Request Proposal of New Course s : MKTG 6752. Revision of Existing Course s : OMGT 6763. Marked Catalog Copy Supporting Documentation Office of the Registrar COB Graduate Curriculum Committee. Memorandum of Request Proposal of New Course s : NUTR 6031. Revision of Existing Program s : Dietetic Internship Revision of Existing Degree s : MS in Nutrition Deletion of Existing Course s : NUTR 5001. Marked Catalog Copy. V College of Education. Memorandum of Request Proposal of New Course s : EDTC 7035. Marked Catalog Copy. Supporting Documentation Office of the Registrar CTE Curriculum Committee. College of Health and Hum...
http://ecu.edu/cs-acad/gcc/GCC-Agenda-April-15-2009.cfm
*  Minutes 10.31.13 School of Medicine at the University of Virginia
... Patient Care. School of Medicine. Curriculum Committee. Curriculum Committee Minutes. NxGen Curriculum. Curriculum Committee. University of Virginia School of Medicine Curriculum Committee Minutes – 10/31/13 Pediatric Conference Room, 4:00 p.m. Identify key components, relationships and policies that comprise the structure, delivery and financing of US health care; Describe how decisions health care professionals and patients make influence the costs of care for patients and society and the income of physicians; Describe the concept of value in health care and the factors that lead physicians to provide care of greater or lesser value Identify, analyze and resolve potential ethical conflicts created by the US health care delivery and financing system. Orientation/Cells to Society Review. Proposed changes for Cells to Society include introducing the topic of nutrition into Orientation or C2S, a Diabetes panel discussion might be preferable to the Diabetes Resource Fair that many students found disorganize...
http://medicine.virginia.edu/education/medical-students/UMEd/curriculum/minutes-10-31.13.html
*  European Journal of Clinical Pharmacology Volume 16 Issue 5 | DeepDyve
European Journal of Clinical Pharmacology Volume 16 Issue 5. Follow. European Journal of Clinical Pharmacology Volume 16 Issue 5. Volume 71. Issue 5 May. Issue 4 Apr. Issue 3 Mar. Issue 2 Feb. Issue 1 Jan. Volume 70. Issue 12 Dec. Issue 11 Nov. Issue 10 Oct. Issue 9 Sep. Issue 8 Aug. Issue 7 Jul. Issue 6 Jun. Issue 4 Apr. Issue 3 Mar. Issue 2 Feb. Issue 1 Jan. Volume 69. Issue 12 Dec. Issue 11 Nov. Issue 10 Oct. Issue 9 Sep. Issue 8 Aug. Issue 7 Jul. Issue 6 Jun. Issue 4 Apr. Issue 3 Mar. Issue 2 Feb. Volume 68. Issue 12 Dec. Issue 11 Nov. Issue 10 Oct. Issue 9 Sep. Issue 8 Aug. Issue 7 Jul. Issue 6 Jun. Issue 4 Apr. Issue 3 Mar. Issue 2 Feb. Issue 1 Jan. Volume 67. Issue 12 Dec. Issue 11 Nov. Issue 10 Oct. Issue 9 Sep. Issue 8 Aug. Issue 7 Jul. Issue 6 Jun. Issue 4 Apr. Issue 3 Mar. Issue 2 Feb. Issue 1 Jan. Volume 66. Issue 12 Dec. Issue 11 Nov. Issue 10 Oct. Issue 9 Sep. Issue 8 Aug. Issue 7 Jul. Issue 6 Jun. Issue 4 Apr. Issue 3 Mar. Issue 2 Feb. Issue 1 Jan. Volume 65. Mikkelsen Department of Clinical Ph...
https://deepdyve.com/browse/journals/european-journal-of-clinical-pharmacology/1979/v16/i5
*  Ex president who swore in President Hoover • Mordo Crosswords - Crossword Puzzle Answers
Ex president who swore in President Hoover Mordo Crosswords - Crossword Puzzle Answers. Mordo Crosswords - Crossword Puzzle Answers. In Mordo Crosswords Blog, We update crossword clues & solutions on a daily regularity. Search How to Become a Pro Crossword Solver Train your brain with crosswords The History of Crosswords Learning a Language with Crossword Puzzles How To Become A Crosswords Guru Really Fast Online Crossword Flash Games How Crossword Puzzles Help Prevent Alzheimer's Disease Privacy Policy A Day in the Life of a Crossword Solver Mordo Crosswords Family Why Is It Important To Solve Crosswords. The Three Useful Steps to Solve Crossword Crossword helps to increase your IQ Crossword Puzzle Solving Tools The role of crossword in increasing your word power Reason to play crossword puzzle 6 Things You Didn't Know About The NY Times Crossword Puzzles Places to Submit Crosswords You've Created Mordo's Blog Crossword Puzzle for Kids How To Create Your Own Crossword Puzzle How to Earn Extra Money with Cros...
http://mordocrosswords.com/2013/10/ex-president-who-swore-in-president.html
*  Elite military unit • Mordo Crosswords - Crossword Puzzle Answers
Elite military unit Mordo Crosswords - Crossword Puzzle Answers. Mordo Crosswords - Crossword Puzzle Answers. Mordo Crosswords is your one-stop online crossword puzzle resource, dedicated to providing you with free puzzle clues, answers, and informative articles to help you with your everyday puzzle needs since 2013. In Mordo Crosswords Blog, We update crossword clues & solutions on a daily regularity. Search How to Become a Pro Crossword Solver Train your brain with crosswords The History of Crosswords Learning a Language with Crossword Puzzles How To Become A Crosswords Guru Really Fast Online Crossword Flash Games How Crossword Puzzles Help Prevent Alzheimer's Disease Privacy Policy A Day in the Life of a Crossword Solver Mordo Crosswords Family Why Is It Important To Solve Crosswords. The Three Useful Steps to Solve Crossword Crossword helps to increase your IQ Crossword Puzzle Solving Tools The role of crossword in increasing your word power Reason to play crossword puzzle 6 Things You Didn't Know About ...
http://mordocrosswords.com/2014/07/elite-military-unit.html
*  India's Rebellion, 1857-59 • Mordo Crosswords - Crossword Puzzle Answers
India's Rebellion, 1857-59 Mordo Crosswords - Crossword Puzzle Answers. Mordo Crosswords - Crossword Puzzle Answers. Mordo Crosswords is your one-stop online crossword puzzle resource, dedicated to providing you with free puzzle clues, answers, and informative articles to help you with your everyday puzzle needs since 2013. Did we help you find the solution. Please, Give us your Like :- If you like puzzles and challenge yourself, you came to the right place. In Mordo Crosswords Blog, We update crossword clues & solutions on a daily regularity. Any definition has wide range of solutions, and all the answers sorted by letters of the alphabet, and by the number of words depending on the need. Click +1, Like and Share to confirm. crossword clue. Articles. Search How to Become a Pro Crossword Solver Train your brain with crosswords The History of Crosswords Learning a Language with Crossword Puzzles How To Become A Crosswords Guru Really Fast Online Crossword Flash Games How Crossword Puzzles Help Prevent Alzheime...
http://mordocrosswords.com/2013/12/indias-rebellion-1857-59.html
*  European Association for Clinical Pharmacology and Therapeutics
... {{Infobox organization name = European Association for Clinical Pharmacology and Therapeutics logo = File:EACPT Organization logo.png. dissolved = footnotes = }} The 'European Association for Clinical Pharmacology and Therapeutics' EACPT is a learned society in the field of clinical pharmacology. 1 At that congress the founding EACPT Council elected an Executive Committee with Sjöqvist as chairman, Michael Orme United Kingdom as Honorary Secretary, Jochen Kuhlmann Germany as Treasurer, and Giampaolo Velo Italy as Vice-Chairman, with 26 European countries as members through their home country clinical pharmacology society or section. 2 The EACPT now includes all national organisations for clinical pharmacology in Europe and provides educational and scientific support for the more than 4000 individual professionals interested in clinical pharmacology and therapeutics throughout the European region, with its congresses attended by a global audience. Aims Activities Summer Schools and Focused Meetings Lifeti...
https://en.wikipedia.org/wiki/European_Association_for_Clinical_Pharmacology_and_Therapeutics
*  Basic and Clinical Pharmacology 1st Edition | 9780838505625 | eCampus.com
Basic and Clinical Pharmacology 1st Edition. eCampus.com. FREE SHIPPING on orders over $59. RETURN YOUR RENTAL. MARKETPLACE. HELP DESK. Search FREE SHIPPING on orders over $59. CART 0 items. Rent Textbooks. Buy Textbooks. Sell Textbooks. eTextbooks. Basic and Clinical Pharmacology by Katzung, Bertram G. Edition: 1st. ISBN13: 9780838505625. ISBN10: 0838505627. Rent Textbook. We're Sorry Sold Out. Used Textbook. We're Sorry Sold Out. New Textbook. We're Sorry Sold Out. Related Products. Basic and Clinical Pharmacology 12/E. Basic and Clinical Pharmacology, 11th Edition. Basic and Clinical Pharmacology 13 E. Basic and Clinical Pharmacology. Basic & Clinical Pharmacology 7th. Basic and Clinical Pharmacology. Basic and Clinical Pharmacology. Summary The most current, authoritative, and comprehensive pharmacology book for medical, pharmacy, and other health science students. Widely respected for its clarity, comprehensiveness, and organization, this pharmacology course book presents the essential concepts that stud...
http://ecampus.com/basic-clinical-pharmacology-5th-katzung/bk/9780838505625
*  How Congress might adjourn | How Congress might adjourn crossword, • Mordo Crosswords - Crossword
How Congress might adjourn. How Congress might adjourn crossword, Mordo Crosswords - Crossword Puzzle Answers. Mordo Crosswords - Crossword Puzzle Answers. Mordo Crosswords is your one-stop online crossword puzzle resource, dedicated to providing you with free puzzle clues, answers, and informative articles to help you with your everyday puzzle needs since 2013. Did we help you find the solution. Please, Give us your Like :- If you like puzzles and challenge yourself, you came to the right place. In Mordo Crosswords Blog, We update crossword clues & solutions on a daily regularity. Any definition has wide range of solutions, and all the answers sorted by letters of the alphabet, and by the number of words depending on the need. Click +1, Like and Share to confirm. crossword clue. Articles. Search How to Become a Pro Crossword Solver Train your brain with crosswords The History of Crosswords Learning a Language with Crossword Puzzles How To Become A Crosswords Guru Really Fast Online Crossword Flash Games How ...
http://mordocrosswords.com/2013/07/how-congress-might-adjourn-how-congress.html
*  Medical Terminology Crossword Puzzle
... make a crossword puzzle make a word search from a reading assignment make a word search from a list of words all crossword puzzles health crossword puzzles health word search puzzles young kids crossword puzzles older children crossword puzzles teenage crossword puzzles adult crossword puzzles simple crossword puzzles easy crossword puzzles moderately challenging crossword puzzles hard crossword puzzles very difficult crossword puzzles big crossword puzzles medical terminology across down opening thin delicate inner membrances of the meninges red cell tiny ball of capillaries electrolytes regulated in the blood and urine by the kidney below the skin cancerous tumor branch of medicine concerned with pregnancy and childbirth internal organs kidney tumor of a gland process of cutting out voice box located in the upper part of the trachea the uterus is abnormality tilted backward pertaining to white cells organ that receives a nervous stimulus and passes it into different nerves thinking personality sensatio...
http://whenwecrosswords.com/crossword/medical_terminology/12162/crossword.jsp
*  Clinical Pharmacologists near Charlestown, MA
... Patients : Sign up for Free. Save doctors hospitals Add private notes Connect at home on-the-go. Doctors :. Update your free profile. healthgrades.com. Doctors. Hospitals. Healthgrades gives you 4 ways to find the right care:. TO FIND:. ENTER: Doctors with experience in your treatment: Health condition e.g. rheumatoid arthritis Medical procedure e.g. total knee replacement. Doctors by their medical specialty: Specialty name e.g. orthopedic surgery. Group practice or hospital: Practice or hospital name e.g. Pinnacle Hospital. Specific Doctor: Doctor's name e.g. Dr. Smith or John Smith. ADVERTISEMENT. Find a Doctor. Find a Clinical Pharmacologist. Massachusetts MA. Charlestown. Charlestown, MA Clinical Pharmacologists. Best Match. Patient Satisfaction. Experience Match. Hospital Quality. ADVERTISEMENT. Clinical Pharmacology. view all. Dr. Moran, MD 7 Maynard Pl Cambridge, MA 02138 3.6 miles away It is hard to see a psychiatrist. Compare Patient Satisfaction. Experience Match. Hospital Quality. Treatment Ex...
http://healthgrades.com/clinical-pharmacology-directory/ma-massachusetts/charlestown
*  JHU Clinical Pharmacology - Overview
... The Division of Clinical Pharmacology at the Johns Hopkins University School of Medicine is part of both the Department of Medicine and of the Department of Pharmacology and Molecular Sciences. An endowment made in 1971 by the Burroughs Wellcome Fund established the Wellcome Professorship and the annual Sir Henry Dale Lecture. Past directors of the Division include Louis Lasagna whose research on the quantitative measurement of pain and the importance of the placebo were seminal; Pedro Cuatrecasas, best known for his discovery of the insulin receptor; and Paul Lietman whose deep interest in anti-infective agents molded the careers of the current faculty. Since 2001 the Division has been directed by Theresa Shapiro, whose interests include the discovery and development of new treatments for malaria and other parasitic infections. Though each faculty member has an individual research program, sometimes with a substantial molecular laboratory component, all clinical studies are conducted in the Division's D...
http://jhuclinicalpharmacology.org/overview/index.asp
*  American College of Clinical Pharmacology
... {{Infobox Organization name = American College of Clinical Pharmacology image = image border = size = 150px caption = membership = |budget = |abbreviation = ACCP formation = 1969 headquarters = Ashburn, Virginia |leader title = leader name = website = }} The 'American College of Clinical Pharmacology' 'ACCP' is a national organization of clinical pharmacology healthcare professionals who seek to advance clinical pharmacology. 1 History and mission Structure Membership Publications Activities Education and information resources References External links. History and mission. In the 1960s, a group of physicians formulated the concept of an organization dedicated to a new branch of pharmacology that dealt with the effectiveness and safety of drugs in humans. As a result of their efforts, the American College of Clinical Pharmacology ACCP was founded on September 11, 1969. 2 The mission is to improve health by optimizing therapeutics and to provide leadership and education that enables the generation, integr...
https://en.wikipedia.org/wiki/American_College_of_Clinical_Pharmacology

John Killaly: John Killaly (1776–1832) was the most significant Irish canal engineer working originally for the Grand Canal company and later, as an engineer, under the Directors-General of Inland Navigation.European Association for Clinical Pharmacology and TherapeuticsNeural drug delivery systems: Neural drug delivery is the next step beyond the basic addition of growth factors to nerve guidance conduits. Drug delivery systems allow the rate of growth factor release to be regulated over time, which is critical for creating an environment more closely representative of in vivo development environments.Antileukemic drug: Antileukemic drugs, anticancer drugs that are used to treat one or more types of leukemia, include:Fragment-based lead discovery: Fragment-based lead discovery (FBLD) also known as fragment-based drug discovery (FBDD) is a method used for finding lead compounds as part of the drug discovery process. It is based on identifying small chemical fragments, which may bind only weakly to the biological target, and then growing them or combining them to produce a lead with a higher affinity.Nanoparticle: Nanoparticles are particles between 1 and 100 nanometers in size. In nanotechnology, a particle is defined as a small object that behaves as a whole unit with respect to its transport and properties.International Journal of Nanomedicine: The International Journal of Nanomedicine is a peer-reviewed medical journal covering research on the application of nanotechnology in diagnostics, therapeutics, and drug delivery systems throughout the biomedical field. The journal was established in 2006 and is published by Dove Medical Press.Gross pathology: Gross pathology refers to macroscopic manifestations of disease in organs, tissues, and body cavities. The term is commonly used by anatomical pathologists to refer to diagnostically useful findings made during the gross examination portion of surgical specimen processing or an autopsy.Charged Aerosol Release Experiment: The Charged Aerosol Release Experiment also known as CARE, is a project run by NASA which will use a rocket to release dust in the upper atmosphere to form a dusty plasma in space. NASA plans to trigger cloud formation around the rocket's exhaust particles.DNA-encoded chemical library: DNA-encoded chemical libraries (DEL) is a technology for the synthesis and screening of collections of small molecule compounds of unprecedented size. DEL is used in medicinal chemistry to bridge the fields of combinatorial chemistry and molecular biology.Community-based clinical trial: Community-based clinical trials are clinical trials conducted directly through doctors and clinics rather than academic research facilities. They are designed to be administered through primary care physicians, community health centers and local outpatient facilities.Adverse event prediction: Adverse event (or Adverse effect) prediction is the process of identifying potential adverse events of an investigational drug before they actually occur in a clinical trial.Protein engineering: Protein engineering is the process of developing useful or valuable proteins. It is a young discipline, with much research taking place into the understanding of protein folding and recognition for protein design principles.Reaction coordinateMonoclonal antibody therapyRNAi-Based Identification System and interference of Specific Cancer Cells: A “classifier” was created to classify cells by identifying specific characteristics of Cervical Cancer. These characteristics were consistent with HeLa cells, which served as the target cell line for cell death.Matrix model: == Mathematics and physics ==High throughput biologyChina Biologic Products, Inc.SEA Native Peptide LigationProximity ligation assay: Proximity ligation assay (in situ PLA) is a technology that extends the capabilities of traditional immunoassays to include direct detection of proteins, protein interactions and modifications with high specificity and sensitivity. Protein targets can be readily detected and localized with single molecule resolution and objectively quantified in unmodified cells and tissues.Polymer blend: A polymer blend or polymer mixture is a member of a class of materials analogous to metal alloys, in which at least two polymers are blended together to create a new material with different physical properties. Section 3.List of pharmaceutical compound number prefixes: This list of pharmaceutical compound number prefixes details a pharmaceutical drug labeling standard. Pharmaceutical companies produce a large number of compounds, which cannot all be given names.Coles PhillipsImmunotherapyNventa Biopharmaceuticals CorporationHistory of nanotechnology: The history of nanotechnology traces the development of the concepts and experimental work falling under the broad category of nanotechnology. Although nanotechnology is a relatively recent development in scientific research, the development of its central concepts happened over a longer period of time.Antisense therapy: Antisense therapy is a form of treatment for genetic disorders or infections. When the genetic sequence of a particular gene is known to be causative of a particular disease, it is possible to synthesize a strand of nucleic acid (DNA, RNA or a chemical analogue) that will bind to the messenger RNA (mRNA) produced by that gene and inactivate it, effectively turning that gene "off".Convection cellATC code N07: ==N07A Parasympathomimetics==Protein primary structure: The primary structure of a peptide or protein is the linear sequence of its amino acid structural units, and partly comprises its overall biomolecular structure. By convention, the primary structure of a protein is reported starting from the amino-terminal (N) end to the carboxyl-terminal (C) end.Nude mouseEthyl groupAgricultural engineering: Agricultural engineering in forestryCell-penetrating peptide: Cell-penetrating peptides (CPPs) are short peptides that facilitate cellular uptake of various molecular cargo (from nanosize particles to small chemical molecules and large fragments of DNA). The "cargo" is associated with the peptides either through chemical linkage via covalent bonds or through non-covalent interactions.Science Translational Medicine: Science Translational Medicine is an interdisciplinary medical journal established in October 2009 by the American Association for the Advancement of Science.Biotechnology Industry Organization: The Biotechnology Industry Organization (BIO) is the largest trade organization to serve and represent the biotechnology industry in the United States and around the world.Anna Edney, "Biosciences Defy U.Marketing authorization: Process of reviewing and assessing the dossier to support a medicinal product in view of its marketing (also called licensing, registration, approval, etc.), finalized by granting of a document also called marketing authorization (MA) (equivalent: product license).Ligand (biochemistry): In biochemistry and pharmacology, a ligand is a substance that forms a complex with a biomolecule to serve a biological purpose. In protein-ligand binding, the ligand is usually a signal-triggering molecule binding to a site on a target protein.FERM domain: In molecular biology, the FERM domain (F for 4.1 protein, E for ezrin, R for radixin and M for moesin) is a widespread protein module involved in localising proteins to the plasma membrane.MicroRNA and microRNA target database: This microRNA database and microRNA targets databases is a compilation of databases and web portals and servers used for microRNAs and their targets. MicroRNAs (miRNAs) represent an important class of small non-coding RNAs (ncRNAs) that regulate gene expression by targeting messenger RNAs.Iranian National Formulary: The Iranian National Formulary (INF) has more than 2,300 molecules registered at the Iran's Ministry of Health, including various strengths and dosage forms. The standards regarding pharmaceutical products in Iran are determined and modified by the Pharmacopeia Council.Biopanning: Biopanning is an affinity selection technique which selects for peptides that bind to a given target.Ehrlich GK, Berthold W, and Bailon P.Nucleic acid secondary structure: The secondary structure of a nucleic acid molecule refers to the basepairing interactions within a single molecule or set of interacting molecules, and can be represented as a list of bases which are paired in a nucleic acid molecule.Biological therapy for inflammatory bowel diseaseSilent mutation: Silent mutations are mutations in DNA that do not significantly alter the phenotype of the organism in which they occur. Silent mutations can occur in non-coding regions (outside of genes or within introns), or they may occur within exons.Concentration effect: In the study of inhaled anesthetics, the concentration effect is the increase in the rate that the Fa(alveolar concentration)/Fi(inspired concentration) ratio rises as the alveolar concentration of that gas is increased. In simple terms, the higher the concentration of gas administered, the faster the alveolar concentration of that gas approaches the inspired concentration.Antiviral drug: Antiviral drugs are a class of medication used specifically for treating viral infections. Like antibiotics for bacteria, specific antivirals are used for specific viruses.Trifunctional antibody: A trifunctional antibody is a monoclonal antibody with binding sites for two different antigens, typically CD3 and a tumor antigen, making it a type of bispecific monoclonal antibody. In addition, its intact Fc-part can bind to an Fc receptor on accessory cells like conventional monospecific antibodies.Alzheimer's Disease Neuroimaging Initiative: Alzheimer’s Disease Neuroimaging Initiative (ADNI) is a worldwide project that provides reliable clinical data for the research of pathology principle, prevention and treatment of Alzheimer’s disease (AD). Multiple research groups contribute their findings of the biological markers to the understanding of the progression of Alzheimer’s disease in the human brain.United States House Committee on Mines and Mining: The United States House Committee on Mines and Mining is a defunct a committee of the U.S.Molecular Foundry: thumbnail|200px|The Molecular Foundry building in Berkeley, CaliforniaCardiovascular Cell Therapy Research Network: Cardiovascular Cell Therapy Research Network (CCTRN) is a network of physicians, scientists, and support staff dedicated to studying stem cell therapy for treating heart disease. The CCTRN is funded by the National Institutes of Health (NIH) and includes expert researchers with experience in cardiovascular care at five stem cell centers in the United States.Abscription: During normal transcription, RNA polymerase transcribes a number of short nonproductive oligonucleotides, and this process is called abortive transcription. The trapped RNAPs have been named abscriptases and the synthesis of specific length oligonucleotides called abscription.Single-chain variable fragment: A single-chain variable fragment (scFv) is not actually a fragment of an antibody, but instead is a fusion protein of the variable regions of the heavy (VH) and light chains (VL) of immunoglobulins, connected with a short linker peptide of ten to about 25 amino acids.Huston, J.DrozitumabMultiple cloning site: A multiple cloning site (MCS), also called a polylinker, is a short segment of DNA which contains many (up to ~20) restriction sites - a standard feature of engineered plasmids. Restriction sites within an MCS are typically unique, occurring only once within a given plasmid.Inflammation: Inflammation (Latin, [is part of the complex biological response of body tissues to harmful stimuli, such as pathogen]s, damaged cells, or irritants.Phase problem: In physics the phase problem is the name given to the problem of loss of information concerning the phase that can occur when making a physical measurement. The name itself comes from the field of x-ray crystallography, where the phase problem has to be solved for the determination of a structure from diffraction data.Gene signature: A gene signature is a group of genes in a cell whose combined expression patternItadani H, Mizuarai S, Kotani H. Can systems biology understand pathway activation?HU-336Breast cancer classification: Breast cancer classification divides breast cancer into categories according to different schemes, each based on different criteria and serving a different purpose. The major categories are the histopathological type, the grade of the tumor, the stage of the tumor, and the expression of proteins and genes.EtoricoxibCentre for Research in Neurodegenerative Diseases

(1/180) R

esearch note: does cost recovery for curative care affect preventive care utilization?  (+info)

(2/180) Issues in the measurement of satisfaction with treatment.

Patients satisfaction with treatments is a growing area of research that has tremendous potential to provide outcome measures for clinical trials and disease management programs. It also has applications in marketing and product development, especially for the treatment of chronic diseases. The objective of this review is to demonstrate that treatment satisfaction is a distinct area of research that has produced some important initial results. We define treatment satisfaction and provide a conceptual framework that clarifies the role of treatment expectations, preferences, and satisfaction in the context of healthcare in general. Nineteen articles were selected from more than 1,400 abstracts and were reviewed for the following information: (1) topics covered; (2) method used to design the measure; (3) descriptive statistics; (4) assessment with respect to the attributes in the Instrument Review Criteria of the Medical Outcome Trust's Scientific Advisory Committee; and (5) covariates. We conclude that some important initial results about treatment satisfaction have been obtained, but that much work remains to be performed. We recommend that future research devote more attention to qualitative research with patients, assessment of the measures, and the covariates presented in the conceptual model. We also recommend that decision makers insist on measures that meet these criteria.  (+info)

(3/180) Impact of electronic imaging on clinician behavior in the urgent care setting.

Although it is intuitively valuable that more expedient delivery of radiographic images and reports to clinicians would improve patient care, it is important to document these outcomes to validate further advances in these areas. We evaluated the care of 215 patients seen at a walk-in clinic to determine what benefit digital imaging is to the patient. Cohorts consisted of all patients for whom specified radiology examinations were ordered during a 7-day period. The first cohort was recruited when analog films were used. The second cohort received examinations performed with computed radiography (CR) acquisition and computer display, which had been in use for 2 years. Patients were categorized as to the type of study they received, as well as whether a staff radiologist was immediately available to read the study. Clinical behavior was characterized by outcome measures of time to final diagnosis, time to final treatment, and need for follow-up. Our analysis demonstrated a reduction in time to final diagnosis that was better appreciated during the times when a staff radiologist was not immediately available. It also suggested that greater time reductions were seen for patients who received extremity examinations than those who received chest, sinus, or rib films. These data suggest that digital imaging is a useful tool to improve clinical outcome of patients seen in the acute care setting.  (+info)

(4/180) Did Osler suffer from "paranoia antitherapeuticum baltimorensis"? A comparative content analysis of The Principles and Practice of Medicine and Harrison's Principles of Internal Medicine, 11th edition.

One of the most important legacies of Sir William Osler was his textbook The Principles and Practice of Medicine. A common criticism of the book when it was first published was its deficiency in the area of therapeutics. In this article, the 1st edition of The Principles and Practice of Medicine is compared with the 11th edition of Harrison's Principles of Internal Medicine. The analysis focuses on the treatment recommendations for 4 conditions that were covered in both books (diabetes mellitus, ischemic heart disease, pneumonia and typhoid fever). Osler's textbook dealt with typhoid fever and pneumonia at greater length, whereas Harrison's placed more emphasis on diabetes mellitus and ischemic heart disease. Notwithstanding Osler's reputation as a therapeutic nihilist, the 2 books devoted equivalent space to treatment (in terms of proportion of total sentences for the conditions). For all conditions except ischemic heart disease, Osler concentrated on general measures and symptomatic care. Throughout Osler's textbook numerous negative comments are made about the medicinal treatment of various conditions. A more accurate statement about Osler's therapeutic approach was that he was a "medicinal nihilist." His demand for proof of efficacy before use of a medication remains relevant.  (+info)

(5/180) Restricted natural language processing for case simulation tools.

For Interactive Patient II, a multimedia case simulation designed to improve history-taking skills, we created a new natural language interface called GRASP (General Recognition and Analysis of Sentences and Phrases) that allows students to interact with the program at a higher level of realism. Requirements included the ability to handle ambiguous word senses and to match user questions/queries to unique Canonical Phrases, which are used to identify case findings in our knowledge database. In a simulation of fifty user queries, some of which contained ambiguous words, this tool was 96% accurate in identifying concepts.  (+info)

(6/180) Detailed diagnoses and procedures, National Hospital Discharge Survey, 1997.

OBJECTIVES: This report presents national estimates of the use of non-Federal short-stay hospitals in the United States during 1997. Estimates of first-listed diagnoses, all-listed diagnoses, days of care for first-listed diagnoses, and all-listed procedures are shown by sex and age of patient and geographic region of hospital. METHODS: The estimates are based on data collected through the National Hospital Discharge Survey for 1997. The survey has been conducted annually by the National Center for Health Statistics since 1965. In 1997 data were collected for approximately 300,000 discharges from 474 non-Federal short-stay hospitals. Diagnoses and procedures are presented according to their code number in the International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM).  (+info)

(7/180) A comparison of observational studies and randomized, controlled trials.

BACKGROUND: For many years it has been claimed that observational studies find stronger treatment effects than randomized, controlled trials. We compared the results of observational studies with those of randomized, controlled trials. METHODS: We searched the Abridged Index Medicus and Cochrane data bases to identify observational studies reported between 1985 and 1998 that compared two or more treatments or interventions for the same condition. We then searched the Medline and Cochrane data bases to identify all the randomized, controlled trials and observational studies comparing the same treatments for these conditions. For each treatment, the magnitudes of the effects in the various observational studies were combined by the Mantel-Haenszel or weighted analysis-of-variance procedure and then compared with the combined magnitude of the effects in the randomized, controlled trials that evaluated the same treatment. RESULTS: There were 136 reports about 19 diverse treatments, such as calcium-channel-blocker therapy for coronary artery disease, appendectomy, and interventions for subfertility. In most cases, the estimates of the treatment effects from observational studies and randomized, controlled trials were similar. In only 2 of the 19 analyses of treatment effects did the combined magnitude of the effect in observational studies lie outside the 95 percent confidence interval for the combined magnitude in the randomized, controlled trials. CONCLUSIONS: We found little evidence that estimates of treatment effects in observational studies reported after 1984 are either consistently larger than or qualitatively different from those obtained in randomized, controlled trials.  (+info)

(8/180) Randomized, controlled trials, observational studies, and the hierarchy of research designs.

BACKGROUND: In the hierarchy of research designs, the results of randomized, controlled trials are considered to be evidence of the highest grade, whereas observational studies are viewed as having less validity because they reportedly overestimate treatment effects. We used published meta-analyses to identify randomized clinical trials and observational studies that examined the same clinical topics. We then compared the results of the original reports according to the type of research design. METHODS: A search of the Medline data base for articles published in five major medical journals from 1991 to 1995 identified meta-analyses of randomized, controlled trials and meta-analyses of either cohort or case-control studies that assessed the same intervention. For each of five topics, summary estimates and 95 percent confidence intervals were calculated on the basis of data from the individual randomized, controlled trials and the individual observational studies. RESULTS: For the five clinical topics and 99 reports evaluated, the average results of the observational studies were remarkably similar to those of the randomized, controlled trials. For example, analysis of 13 randomized, controlled trials of the effectiveness of bacille Calmette-Guerin vaccine in preventing active tuberculosis yielded a relative risk of 0.49 (95 percent confidence interval, 0.34 to 0.70) among vaccinated patients, as compared with an odds ratio of 0.50 (95 percent confidence interval, 0.39 to 0.65) from 10 case-control studies. In addition, the range of the point estimates for the effect of vaccination was wider for the randomized, controlled trials (0.20 to 1.56) than for the observational studies (0.17 to 0.84). CONCLUSIONS: The results of well-designed observational studies (with either a cohort or a case-control design) do not systematically overestimate the magnitude of the effects of treatment as compared with those in randomized, controlled trials on the same topic.  (+info)


Earth Therapeutics Lotion, question to those who have used it?


does the  earth therapeutics green tea herbal lotion smell like medicine/green tea ish? pelase tell me because i want to buy it, and the only way i can buy it is online shopping and i want to see what it smells like, anyone used it before? what's the smell like?
----------

a little. but i like it!


Which is better for a pedicure Barefoot or Earth Therapeutics?


Which one is better for a good pedi? And is barefoot generic and what products by what make should i buy?
THANKS
----------

pedicure feels good thats all i know

ANSWER MINE PLEASE - 10 points

http://answers.yahoo.com/question/index;_ylt=AuXBnlHzdouFvJhf52Jv2cTsy6IX;_ylv=3?qid=20090615185550AAq3jFp


Do the eye treatments from Earth Therapeutics Work?


I am curious about the hydrogel undereye patch, recover-e cucumber eye pads and the rejuvenal-c orange eye pads.
----------

That's funny....I just bought those last week and tried them Sat. night along with the eye mask that came with them.....my bags weren't very bad that day but they did seem to help and they felt so much cooler and relaxed. They smell wonderful too.


which book you will prefer for clinical pharmacy and therapeutics?


Goodman and Gelman is still  the gold standard text.  But it was Clinical Pharmacology Made Ridiculously Simple that got me through med school.


did you know about the Frourth National Clinical Conference on Cannabis Therapeutics?


Held Apirl 6-8 2006 in Santa Barbara Calif.
The purpose of the Conference series is to educate the health care professionals and the U.S. public about therapeutic cannabis. There will be guest speaker from all around the world There is alot of good information at this conference
----------

Cannabis is a gift from God.


aim of therapeutics in field of pharmacy?


i want to know details of aim and objectives of therapeutics in field of pharmacy.
----------

well,i just have to be honest with you!right!its not so hard to figure so far its been a particular thing that must have been passed thru just right before you have gotten hired! but i have not  learned all about that out there,but from people around!so annoying to make me understood all about this thing!.


Will CV Therapeutics MERLIN trial (Ranexa) hit its endpoint, showing it's safe? Will it be effective for ACS?


The MERLIN trial is over and Ranexa is being analyzed for safety vs placebo and for efficacy for ACS patients.  The TIMI Group is conducting this trial.
----------

It's too premature to say anything. However you cannot take risk on ACS protocols. Wait for the complete and approval by FDA.


Jobs with Athletic Therapeutics?


what jobs fall under that major?
----------

Geriatric work with seniors; physical therapist working with all ages.